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ABSTRACT
TORY L. CHAMPLIN. Use of the C18 (Octadecyl) Solid Phase
Extraction Coltimn for Wastewater Toxicity Identification and
Characterization (Under the direction of DR. FRANCIS A.
DIGIANO).
Biomonitoring requirements are continually being added
to NPDES permits.  As a result, many municipal wastewater
treatment facilities have been identified as having effluent
acute toxicity.  To solve this problem, the Environmental
Protection Agency (EPA) has developed a Toxicity
Identification Evaluation (TIE) protocol.  This protocol
lists a set of simple procedures which are used to separate
whole effluent samples into different fractions containing
different classes of similar compounds.  Toxic fractions are
further separated and concentrated using various techniques
to assist in the possible identification of certain classes
of suspected toxic compounds.  Once sample fractionation and
toxicity testing have been thoroughly investigated,
chemical-specific analyses are conducted to tentatively
identify toxic constituents.
The C18 (Octadecyl) Solid Phase Extraction (SPE) Column
is used in the TIE protocol to separate and concentrate
moderately polar to nonpolar organic compounds from toxic
effluent samples. An increasing gradient of methanol (MeOH)
in water is used to elute the column; the objective is to
separate retained compounds into eight different fractions
based on their polarity.  The objective of conducting this
research is to determine if the C18 SPE Column elution
procedure is a viable technique for the identification and
characterization of toxic effluents.
This study showed that the C18 column was able to
remove compounds causing acute toxicity from samples
collected at the Cross Creek Wastewater Treatment Plant
(WWTP) in Fayetteville, NC.  The 80 to 85 percent MeOH/H20
fractions contained the most toxicity.  However, laboratory
tests of the procedure using known target compounds
indicated that several different MeOH/H20 fractions
contained each individual compound thus showing deficiencies
in resolution.  Moreover, the target compounds that were
selected differed widely in polarity (as indicated by the
compounds octanol/water partitioning coefficient), yet this
did not cause a wide separation of these compounds into
specific MeOH/HjO fractions. This research showed the C18
SPE column is capable of retaining relatively non-polar
compounds as indicated by the target compound evaluation.
These compounds were effectively eluted from the CIS SPE
column with MeOH/H20, but separation was not well defined.
In the situation of toxic wastewaters, where numerous non-
polar organic compounds may possibly be present in WWTP's
discharge, the C18 SPE column provides little information
regarding the identity of the non-polar organics causing
toxicity in a toxic MeOH/H20 fraction.
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I.  INTRODUCTION
A.  Background
The Water Quality Act of 1987 established water
quality-based permit limitations on all toxic pollutants.
The intent of this law is to go beyond technology-based
approaches that simply require installation of wastewater
treatment facilities in order to protect water quality.
Instead, the water quality based approach uses the
combination of both whole effluent toxicity testing and
chemical-specific analyses for controlling toxic pollutants.
As a result, states are adding biomonitoring to their permit
regulations.  Toxicological data gathered in the early to
mid 1980s indicated that approximately 79% of the municipal
wastewater treatment facilities in the United States had
effluents that were acutely lethal to aquatic life (1).
To assist permittees violating NPDES biomonitoring
toxicity requirements, EPA has developed Methods for Aquatic
Toxicity Identification Evaluation (TIE) protocol.  This
protocol lists a network of procedures which integrate
analytical chemistry with acute toxicity testing.  It
supersedes an earlier EPA approach to toxicity elimination
which focused only on identification of the 126 Priority
Pollutants.  The TIE protocol, on the other hand, makes no
attempt initially to use a chemical specific approach to
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toxicity identification.  Effluent samples are separated
into different fractions (based on general chemical
properties), each containing different classes of similar
compounds.
Many sources contribute toxicity to publicly owned
treatment works (POTWs), including industrial, commercial
and domestic wastes.  The toxic constituents are broadly
categorized into five groups by the TIE protocol based on
chemical characteristics.  These include oxidants, metals,
volatiles, solids and organic compounds.  The C18 SPE (Solid
Phase Extraction) Column is used to extract and concentrate
moderately polar to non-polar organic compounds from
wastewater samples.  A reduction in acute toxicity measured
before and after sample passage indicates non-polar organics
as a possible source of toxicity.  Once this determination
has been made, the C18 column can be used to elute and
concentrate the retained organic compounds for further
refined testing.
B.  Research and Objectives
The main focus of this research is to investigate the
use of the C18 Octadecyl Solid Phase Extraction Column in
Phase II Toxicity Identification Procedures of the TIE
protocol.  The objectives of conducting this research are:
1.  to show the differences in sensitivity between the
Ceriodaphnia and Microtox as aquatic toxicity
indicators,
to evaluate the C18 SPE Column elution procedure by
using selected target compounds of known toxicity and
polarity and examine a possible correlation between
the methanol/water fraction that elutes
toxicity and the log octanol/water partitioning
coefficient of these target compounds
3.  to test the 018 SPE Column procedure with actual
effluent samples collected from POTW's in Highpoint
and Fayetteville, North Carolina.
kII.  LITERATURE REVIEW
A.  C18 SPE Column
Solid Phase Extraction (SPE) was introduced in the mid
1970's as a organics analysis preparation technique (2).
Prior to this time, the traditional liquid-liquid extraction
conducted in separatory funnels was the popular approach.
The objective of either technique is to prepare a sample for
instrumental analyses. Sample cleanup and concentration are
important for gas chromatography (GC) and high pressured
liquid chromatography (HPLC).  The removal of impurities
from a sample matrix is required when they interfere with
analyte measurements or possibly shorten the life of GC or
LC capillary columns.  Sample concentration is essential
when the measured analytes are too dilute for direct
measurement.
In terms of the TIE, the SPE process was adapted to
extract suspected non-polar organics from wastewater
samples.  Toxic organic constituents found leaving
wastewater treatment facilities are typically at
concentrations too low to be effectively identified by
current analytical techniques. Using SPE allows for the
separation as well as the concentration of these compounds
so that further toxicity testing and chemical analyses may
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be conducted.
The concept of the SPE test recommended by EPA in its
TIE protocol is similar to low pressure liquid
chromatography.  A small, disposable SPE column can contain
a variety of possible sorbents.  Figure 2.1a shows the
schematic diagram of a typical column (3).  The
polypropylene reservoir can vary in size ranging from 1 to 6
ml in capacity.  The columns are prepacked by the
manufacturer (J.T. Baker) with 100, 200, 500 or 1000 mg of
sorbent sandwiched between two, 20-micron polyethylene
frits.
Figure 2.1b illustrates the process of solid phase
extraction (3).  The first step is to condition the column
with an appropriate solvent (e.g., methanol, hexane or
chlorofoirm) .  This activates the functional groups of the
sorbent.  In addition, a small volume of sample is applied
and wasted to remove any portion of remaining solvent.  The
sample is forced through the column either by aspiration or
positive pressure.  Sample application is followed by column
washing.  Impurities or possible interferences retained by
the column can be selectively removed by an appropriate
solvent leaving the analytes remaining.  The last step in
the process is to elute the purified analytes from the
column.  This can be accomplished by the selection of a
solvent strong enough to displace the analytes from the
sorbent.
Two of the major SPE categories are normal and reversed
SOLID   PHASE  EXTRACTION
DISPOSABLE COLUMN ,
Figure 2.1a
ͣSAMPLE   RESERVOIR
(POLYPROPYLENE)
-FRITTED DISC
(20pm POLYETHYENE)
-SORBENT |ED
(40pnn60Aor275A)
FRITTED   DISC
LUER TIP
SOLID   PHASE EXTRACTION   STEPS
CONDITIONING
^ 1
Figure 2.1b
SAMPLE
APPLICATION
WASHING
•-•*
f
V
ELUTION
Figure 2.1 The C18 Solid Phase Extraction Column  (a)  A
Schematic Diagram Illustrating the SPE
Disposable Column and  (b)   Solid Phase
Extraction Process.
(
7phase chromatography.  Normal phase chromatography (NPC)
refers to a system where the sorbent is more polar than the
mobile phase or sample solution whereas reversed phase
chromatography (RPC) refers to the opposite.  Silica,
kieselguhr, alumina and Florisil (activated magnesium
silicate) are commonly-used, normal phase adsorbents in the
separation of polar compounds from relatively nonpolar
solvents (4).  Reversed phase chromatography came about from
the synthesis of bonded sorbents in the late 1960's.  The
free silanol groups of silica were treated with mono-, di-,
tri-halo or alkoxy silyl derivatives to form siloxanes.  The
original intent of bonded silica was to create a non-polar
adsorbent; however polar bonded phases were also developed.
The eluotropic strength of a solvent used in SPE
procedures is represented by E°.  The eluotropic series
shown in Table 2.1 is an arrangement of a group of solvents
in order of decreasing strength for elution of analytes from
pure silica and was determined experimentally.  Other
eluotropic series have been developed and are available in
the literature for other sorbents.
Table 2.1 lists some commonly used chromatographic
solvents according to their E° and p' (polarity index) for
silica.  Both of these indices are important to consider
when designing an extraction process (2).  The polarity
index ranks chromatographic solvents according to their
solvating ability for a variety of test solutes. This index
was developed to assist analysts using liquid-liquid
8Si - 0 \^    >-0 - Si(CH3)3
Si
Si - 0-^  ^(C«2>17^"3
Figure  2.2  Chemical Structure of Octadecyl Sorbent
with Trimethylchlorosilane Endcapping.
Table 2.1
Solvent Eluotropic Strength and Polarity (2)
Solvent E°*      p'**
Acetic Acid, Glacial
Water
Methanol
Z-Propanol
Pyridine
Isobutyl Alcohol
Acetonitrile
Ethyl Acetate
Acetone
Methyl Ethyl Ketone
Tetrahydrofuran
Methylene Chloride
Chloroform
Tert-Butyl Methyl Ether
Ether, Anhydrous
Benzene
Toluene
Carbon Tetrachloride
Cyclohexane
Pentane
n-Hexane
n-Heptane
Hexanes
* E° = eluotropic strength, eluting solvent strength on
silica.
** P' = polarity index, measure of solvent's ability to
interact as a proton donor, proton acceptor or
dipole.
>0.73 6.2
>0.73 10.2
0.73 6.6
0.63 4.3
0.55 5.3
0.54 3.0
0.50 6.2
0.45 4.3
0.43 5.4
0.39 4.5
0.35 4.2
0.32 3.4
0.31 4.4
0.29 -
0.29 2.9
0.27 3.0
0.22 2.4
0.14 1.6
0.03 0.0
0.00 0.0
0.00 0.06
0.00 0.2
0.00 0.06
9extraction (conducted typically in separatory funnels).
The eluotropic series was developed to aid in liquid-
solid chromatography (SPE).  For the series listed in Table
2.1, the sorbent is pure silica and the chromatographic
phase is normal (NPC).  As can be seen, the eluotropic
strength and the polarity index do not always correspond.
This is why it is important to include both indices when
designing an extraction process.  For example, isobutyl
alcohol (E° = 0.54) has a higher eluotropic strength than
acetonitrile (E° = 0.50), indicating a higher degree of
solvating strength on pure silica.  However, the
corresponding polarity index shows isobutyl alcohol (p'=
3.00) having a lower degree of polarity than acetonitrile
(p'= 6.20).  In the case of NPC/SPE, acetonitrile would be
considered to have a higher degree of solvating strength for
elution of analytes from pure silica even though isobutyl
alcohol has a higher polarity.
The C18 SPE Column used in the TIE protocol is composed
of a porous silica sorbent which has been treated with a
single layer of octadecyl groups (5).  This non-polar,
bonded-phase attracts non-polar compounds and metal chelates
(which are soluble in hexane and chloroform) strongly from
an aqueous sample.  The stationary phase (sorbent) is less
polar than the mobile phase (sample); this is RPC.
Figure 2.2 shows the structure of the octadecyl sorbent
with the addition of the trimethylchlorosilane endcapping.
Octadecyl substituted siloxanes are capable of extracting
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nonpolar to slightly polar analytes from solvents having E°
(eluotropic strength of adsorption on pure silica) values
greater than approximately 0.6 (Table 2.1).  The analytes
are eluted from the column with solvents having lower E°
values (2).
The column elution procedure as outlined in Phase II
Toxicity Identification Procedures of the TIE protocol
designates methanol (E° = 0.73) as the eluting solvent (5).
However, methanol (MeOH) is one of the weaker solvents to
use in reversed phase chromatography (RPC) where wastewater
(E° > 0.73) is the mobile phase and the sorbant (less polar)
is the stationary phase. The objective would be to choose
an eluting solvent that has an E° much less than that of
wastewater.  Therefore, a far better solvent than MeOH would
be hexane (E° = 0.0); this would also facilitate GC/MS
analyses.  Unfortunately, hexane is not miscible in water
nor is it nontoxic to the test organisms.  Miscibility and a
non-toxic response are essential to verification of toxicity
in the column elution procedure.  MeOH (E° = 0.73), on the
other hand, meets these two important criteria.  However,
MeOH is not a very good solvent to use to GC/MS analysis,
because it will shorten the life of capillary columns (5).
Nevertheless MeOH is used because of its low toxicity and
ability to elute compounds from a C18 column.
The intermolecular interactions between the analyte
molecules and the octadecyl functional groups on the sorbent
create the separation mechanisms which allow for the
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extraction process to work.  The intermolecular forces which
play a key role in the separation process are:  ionic
interactions, hydrogen bonding, dipole-dipole, dipole-
induced dipole and dispersion forces (induced dipole-induced
dipole) (2).  Figure 2.3 illustrates the diester dibutyl
phthalate as it is partitioned onto the C18 bonded phase.
The octadecyl bonded phase is considered the most
versatile in terms of retaining a wide range of different
compounds as compared with the other RPC sorbents that are
available.  Various applications are listed in Table 2.2.
It is also considered to have the highest degree of
retention for non-polar analytes.  Under certain
circumstances the interactions between some analytes and the
sorbent may be too significant to be disrupted by the
eluting solvent.  A less polar solvent or a change in the
bonded phase to a shorter alkyl chain (octyl, butyl or
methyl) could solve this problem.  However, changing the
solvent or sorbent must not cause toxicity or other
interferences.
B.  C18 SPE Column Procedure (TIE Protocol)
A detailed description of the C18 SPE Column procedure
is given in the EPA Guidance Documents describing Phase I
(6) and Phase II (5).  Figure 2.4 is an overview of the
Phase I Toxicity Characterization Procedures (6).  The
reference to Day 1 and Day 2 identifies the time at which
toxicity testing is conducted on the specified aliquots.
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Si
Si - 0
Si
0 -Si(CH3)3
0
II
(CH2)^7CH3......H3C(CH2)3 - 0 - C
••H3C(CH2)3 - 0 - C Q
Q
Figure 2.3 Chemical Structure of Reversed Phase
Partitioning Using Solid Phase Extraction.
(Sorbent: Octadecyl, Analyte: Dibutyl Phthalate)
Table 2.2
Applications for Reversed Phase Extraction Columns (2)
Sorbent Application
Octadecyl (C^g)
Octyl (Cg)
Abused Drugs, Acetaminophen, Amines,
Analgesics, Anthraquinones, Antiarrthmics,
Anticonvulsants, Antiepileptics,
Antibiotics, Aromatics, Barbiturates,
Benzodiazepines, Caffeine, Cannabis,
Carbohydrate Carboxylic Acid, Carotenoids,
Cholesterol Esters, Dye Intermediates,
Essential Oils, Ethchlorvynol,
Ethosuximide, Fatty Acids, Food
Preservatives, Fungicides, Hydrocarbons,
Hypnotics, Lidocaine, Lipids, Oil Soluble
Vitamines, Phenols, Phthalate Esters,
Priority Pollutants, (Pesticides, PNA's,
RAH, PCB's), Sedatives, Steroids,
Sulfonamides, Surfactants, Tetracyclines,
Theophylline, Tricyclic Antidepressants,
Triglycerides, Valproic Acid.
Priority Pollutants (Pesticides, PNA's,
PAH's, PCB's) and other compounds adsorbed
too tightly to Octadecyl (C18).
Phenyl (CgHg) Offers less retention of hydrophobic
compounds.
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Toxic Effluent Saiifsle
Baseline
Toxicity
Test
(Day 2)
Initial
(Day 1)
Aeration
Test (Day 2)
Acid PHl Base
Filtration
Test (Day 2)
\ '
i i
Acid PHl Base
pH Adjustsnent
Test (Day 2)
fTTi
Acid
i
EDIA
Chelation
Test
(Day 2)
Oxidant
Reduction
Test
(Day 2)
C^g Solid Phase
Eictraction Test
(Day 2)
Acid PHl Base
Graduated pH Test
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Figure 2.4 Overview of Phase I Effluent Characterization
Tests (6) (Note: pH(I) stands for the initial pHof the sample)
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Day 1 is considered the day when the effluent sample arrives
in the laboratory.  On this day the manipulative procedures
are conducted and the different aliquots are generated.  Day
2 is the initiation of toxicity testing on the fractions
generated from the previous day.  Initial and baseline
toxicity tests are conducted to identify and to insure the
continual presence of toxicity.  The baseline test is
considered the norm for the toxicity measurements taken of
the aliquots.
As shown in Figure 2.4, the bioassays for the C18 Solid
Phase Extraction Test are conducted on Day 2.  Three
different aliquots are passed through three conditioned
columns.  Two of the aliquots are adjusted to pH 3 (to
remove uncharged organic acids) and 9 (to remove uncharged
organic bases); the uncharged form of organic acids and
bases is less polar and thus able to be retained by the C18
column.  The pH of all of the aliquots generated by Phase I
testing are readjusted back to the initial pH (pHI) of the
sample before toxicity tests are conducted.  Bioassays are
performed on aliquots taken before and after the column.  If
a noticeable reduction in toxicity is indicated by the test,
then Phase II efforts will focus on the C18 column elution
procedure.  However, if the test indicates no reduction in
toxicity, no elution is needed.
The identification of the nonpolar organic toxicants is
accomplished in Phase II Toxicity Identification Procedures
of the TIE protocol. Figure 2.5 shows the general process
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Fractions*
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Compare Concentrations to LC50 Values
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Figure 2.5 Schematic for Phase II Identification of 018Column Retained Toxicants (6)
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used to identify the toxic analytes.  In this phase, the C18
column is used to extract, concentrate and elute the toxic
analytes from the effluent sample.  A large portion of
sample (about 1 liter) is passed through the column.  The
sample pH may be adjusted depending on the results from
Phase I.  Obviously, the pH that caused the largest decrease
in toxicity would be used in this procedure.  As with Phase
I C18 column tests, the toxicity of the aliquots before and
after passage through the column verify the retention of
toxic compounds and insure the capacity of the column to
remove toxicants has not been reached.
A column that contains toxicity causing compounds is
eluted sequentially with small volumes of 25, 50, 75, 80,
85, 90, 95 and 100 percent MeOH/H20 mixtures.  The
increasing solvent gradient is used to separate and remove
the retained analytes in terms of their decreasing polarity
and solubility.  These MeOH/H20 fractions are then tested
for toxicity.  Those which show significant toxicity are
combined together, diluted one to ten with high purity water
and passed through a smaller C18 column.  Another elution is
performed, in this instance using a small volume of 100
percent MeOH.  The purpose of this step is to concentrate
the analytes even further and eliminate water from the
mixture.  The eluted fraction is tested for toxicity to
insure that the toxic analytes are still present. It also
allows for recovery estimations to be determined of the
toxic analytes by comparing toxicity values of the eluent
k17
and the whole effluent sample. A recovery of 100% is not
crucial at this point, but significant toxicity should be
present for the analysis to continue.
The concentrated eluent is injected into a reversed
phase, HPLC column.  In the initial stages of testing, the
C18 packing used in the SPE column is also used in the HPLC
column; these differ only in particle size with that used in
HPLC being much smaller.  As more is known about the toxic
analytes, other HPLC packed columns may be utilized to
achieve better resolution.
As with the SPE column, the HPLC column is eluted with
a concentration gradient of MeOH and water.  The elution
gradient begins at 30 percent MeOH/H20 and continues to 100
percent MeOH.  Twenty-five fractions are collected and
tested for toxicity.  The toxic fractions are concentrated
again through a small C18 SPE column.  This step, as before,
concentrates the analytes and eliminates the presence of
water.  Judgment is required to determine if the toxic
fractions should be concentrated separately or combined.
This is crucial when considering the cost of GC/MS analyses.
For example, if three successive fractions are determined to
be toxic, the probability that the same toxicant is present
in all three is fairly reasonable (5).  These three
fractions could be combined reducing the work load.  The
concentrated fractions are tested for toxicity.  This
verifies the presence of toxicity and allows for recovery
estimations to be made.
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The final step in the identification of the toxic
compounds is GC/MS analyses.  The concentrated fractions
generated from the HPLC stage of the procedure are injected
onto a capillary column.  MeOH, as mentioned before, is not
a typical solvent used for GC  analysis.  However, MeOH is
required for toxicity verification.  The life of a capillary
column will be shortened by the injection of MeOH, and
routine GC/MS QA/QC procedures are necessary to monitor
column performance.  Once the mass spectral data have been
generated, peak detection and integrated algorithms can be
used to reduce the data (5).  A library search is conducted
to identify all detectable peaks.  A list of identified
compounds is assembled and confirmed using various
techniques outlined in Phase II and Phase III of the TIE
protocol.  If the spectral analysis is cluttered by the
presence of numerous compounds, then the HPLC fractionation
technique may be modified to attain higher resolution.
C.  Toxicity Identification Evaluation Studies Using the SPE
Procedure
As of this writing, no TIE result oriented studies have
been published in the Journal of the Water Pollution Control
Federation (JWPCF) or in Environmental Toxicology and
Chemistry (SETAC).  Many papers have been presented on the
TIE topic at annual professional meetings (WPCF and SETAC),
but as of yet non of these have been published in their
respective journals.  The only source of information found
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is published by EPA (7, 8, 9).  However, many of these
documents are still in draft form and are not for public
release.  Additionally, EPA has not published any data to
show the development of the C18 SPE Column procedure.  This
lack of supportive information has made it difficult to
understand EPA's rationale for the procedures developed.
The EPA sponsored studies using the C18 column
procedure were conducted at the Largo WWTP in Largo, Florida
(7), the Akron POTW in Akron, Ohio (8) and the Patapsco WWTP
in Baltimore, Maryland (9).  All three indicated a
significant reduction in toxicity when the effluent samples
were passed through a CIS SPE column.  Non-polar organic
compounds would therefore appear to have been the major
toxic constituents in the effluent streams of all three
treatment facilities.
The limited results received from the study conducted
at the Largo WWTP (7) are summarized in Table 2.3.
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Table 2.3
Solid Phase Extraction Toxicity Test Results,
Largo WWTP, Largo, Florida (1985)
Percent MeOH/HjO
Date/Type     25    50    75    80    85    90   95    100
Oct.24,1985/C -     -     _    _      T
Oct.24,1985/C  -     - *
Dec.l6,1985/C t     *     T   T     T
* denotes toxic peak
- denotes not tested
C = composite sample
T = toxicity found in that fraction
Samples collected on October 24 were used to establish if
the C18 column was capable of extracting and eluting toxic
analytes from the effluent stream.  A toxicity peak was
found at 80 percent MeOH/H20 (see second entry in Table
2.3).  The third sample, collected approximately on December
16, 1985, showed that the toxicity peak had shifted to the
85 percent MeOH fraction.  The 85 and 90 percent MeOH/HjO
fractions of this sample were then taken to dryness and
reconstituted with dilution water to check for toxicity;
both showed complete mortality of Ceriodaphnia within 24 hr.
The results from the Largo WWTP suggested that the
toxicants, in addition to being relatively non-polar, are
also relatively non-volatile (7). The shift in toxicity
peak suggested by the data in Table 2.3 may indicate
variability in the sources of toxicity.  However, these data
are too limited to make firm conclusions.
Table 2.4 is a summary of the column elution results
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obtained from testing the effluent from the Akron POTW in
Akron, Ohio (8).
Table 2.4
Solid Phase Extraction Toxicity Test Results,
Akron POTW, Akron, Ohio (1986)
Date/Type 25 50
Percent MeOH/HoO
75    80    85    90 95 100
Jan 13,1986/C
Jan 14,1986/C
Jan 15,1986/C
Feb 8,1986/C
Feb 9,1986/C
Mar 28,1986/C
Mar 29,1986/C
Mar 30,1986/C
Apr 22,1986/lG
/2G
/3G
/4G
Jul 10,1986/2G
Aug 6,1986/G
Aug 14,1986/C
Aug 18,1986/C
Aug 26,1986/C
T
T
T
T
T
T
T
T
T
T
T
T
T
T
- denotes not tested
C = composite, G = grab sample
T = toxicity found in that fraction
T
T
T
T
T
T
The 85 percent MeOH/H20 fraction contained most of the
toxicity.  However, toxicity was also found in the 100
percent MeOH fraction.  Because the toxicity was found in
the higher percent MeOH/HjO fractions, the toxic compounds
were considered relatively non-polar.  Additionally, the
appearance of toxicity in the 100 percent MeOH/HjO fraction
was only observed when mortality of the Ceriodaphnia ensued
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rapidly in the 85 percent MeOH/H20 fraction (8).
The C18 column was also tested at the Patapsco WWTP in
Baltimore, Maryland (9).  Many industrial sources contribute
to the influent stream of this facility.  Acute toxicity
using Ceriodaphnia is observed on a continual basis.  Table
2.5 shows the column elution results from testing the
primary and secondary effluents (9).
Table 2.5
Solid Phase Extraction Toxicity Test Results
Patapsco WWTP, Baltimore, Maryland (1986-1987)
Date/Origin 25
Percent MeOH/HoO
50   75   80   85   90 95 100
Jul  9,1986/2nd Eff t
Jul 23,1986/Pri Eff t
Jul 23,1986/2nd Eff t
Dec 10,1986/2nd Eff t
Jan  6,1987/2nd Eff t
Jan 8,1987/2nd Eff
t t t T * T t
t t T T * T t
t t T T * T t
t T T * T t t
t T
t
T
T
*
*
T t t
* denotes toxic peak
T = significant toxicity found in that fraction
t = slight toxicity found in that fraction
Primary Effluent (Pri Eff)
Secondary Effluent (2nd Eff)
Toxicity was present over a wide range of MeOH/HjO
fractions.  This would indicate that the effluent stream
contains a complex variety of non-polar organic compounds.
The shift in the toxic peak from 90 percent to the 85
percent MeOH/H20 fraction was suggested to be seasonal;
however no explanation for this change in peak values was
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offered.
An attempt was made during the Patapsco study to
identify the toxic constituents found in each MeOH/H20
fraction found to contain toxicity.  The GC/MS analyses did
not show the presence of suspected toxic compounds (9).  In
fact, the majority of the chromatographic peaks could not be
identified and for the few which could, they did not appear
to be the cause of toxicity.
The operational and managerial viewpoint of the
Toxicity Reduction Evaluation conducted at the Patapsco VJWTP
was recently presented (10).  The column elution procedure
was criticized for not yielding meaningful results.  The
procedure was found to produce poor spectral analysis
through GC/MS.  This was claimed to be caused by too many
compounds being present in the influent or effluent of a
large municipal wastewater treatment plant.  The results
obtained with the C18 column fractionation technique were
noted to be similar to those at the Akron WWTP in Akron,
Ohio.  Yet, these treatment facilities have different
industrial sources.  Therefore, it was difficult to explain
why samples from two plants showed toxicity in the same 85
percent MeOH/H20 fraction.  The procedure was recommended
for use as a research tool but not as a practical technique
for wastewater treatment plant personnel.
III.  EXPERIMENTAL PROCEDURE
A.  C18 SPE Column Procedure
A.l  C18 SPE Column Set-up and Conditioning
The CIS SPE column procedure was followed exactly as
presented in the EPA Phase I Toxicity Characterization
Procedures Guidance Document (6).  This procedure, however,
deals only with passage of samples through the CIS SPE
Column and subsequent measurements of toxicity after
passage.  While this research was underway, EPA published
(November 1988) its Phase II Toxicity Identification
Procedures in draft form (5).  This aspect of the procedure
deals with elution of MeOH/HjO fractions and measurements of
their toxicity.  Unfortunately, much of the elution work had
already been done for this study when the EPA document
became available.  The elution procedure was developed from
the limited information found in specific extracts sent by
EPA from the City of Largo evaluation (11) and Las Vegas
report (12).  The procedures used closely resembled those
adopted by EPA in the draft report of Phase II; differences
between them will be addressed.
The experimental setup for conducting the column
elutions is shown in Figure 3.1.  It consists of a sample
reservoir (1 liter volume), needle valve, C18 SPE Column and
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COLLECTION  VIAL
Figure 3.1 Experimental Setup for Phase II  C18  SPEColumn Sample Application.
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vacuum flask.  A rubber stopper held the glass tubing that
was used to extract the sample and vent the interior space
of the reservoir bottle.  The extraction tube was bent to
allow easy access to the last remaining portions of sample.
A needle valve controlled the flowrate of the column.
During the design of this setup it was discovered that the
stopper used on the discharge tube of a standard 250 ml
filtration apparatus was ideal for holding the C18 SPE
column.  Additionally, a looped piece of piano wire was
inserted into the vacuum flask on the outer edge of the
rubber stopper to hold the sample collection vials and to
allow easier control of the vacuum process through the
continual bleeding of the pressure.
The column was first conditioned with MeOH.  The column
manufacturer (J.T.Baker) suggests 10 ml of MeOH followed by
a 10 ml rinse with high purity water (3); however, the EPA
Phase II Draft Document recommends increasing this to 25 ml
(5).  The manufacturer's procedure was used here.
After conditioning, 3 ml of each MeOH/H20 elution was
passed through and collected in analytically clean vials.
These fractions served as controls to determine if the
interaction between MeOH and the column sorbent was causing
toxic interferences.
The MeOH/H20 elution process is shown in Figure 3.2.
The 5 ml syringe, containing 3 ml of the MeOH/H20 mixture
and 2 ml of headspace, was inserted into the column adaptor.
The syringe was carefully depressed to allow the mixture to
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Figure 3.2 Experimental Procedure for Phase II C18 SPE
Column Elution Process.
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flow through the column at a rate of 5 ml/min or less.  The
2 ml headspace was required to expel the remaining fluid
from the packing.  Each elution was collected in a separate
vial and labelled for toxicity testing.  At this point, EPA
suggests the column should be allowed to dry between each 3
ml elution volume and a maximum flow rate of 4 ml/min should
not be exceeded (6).  The column was not extensively dried
beyond the 2 ml headspace required to flush-out the
remaining MeOH/H20 mixture.  A maximum flow rate of 5 ml/min
was used as prescribed by the manufacturer (3).  After the
column elution blanks were passed, the column was
reconditioned with 10 ml of MeOH followed by 10 ml of high
purity water.
A.2  Sample Application
Each sample was processed by first filling the reservoir
bottle with one liter of sample.  The conditioned column was
inserted in the rubber stopper and placed in the top of the
vacuum flask. Figure 3.1.  The sample feeding line (1/8 inch
OD, Teflon TFE tubing) was inserted into the adaptor of the
column.  Air must be removed from this line; otherwise, the
column will become partially dry.  The packing must not be
allowed to dry between conditioning and sample application.
The system was primed by first inserting the feeding line
into the adaptor of a so-called, "waste column". This
column was inserted into another rubber stopper and placed
in the vacuum flask.  The needle valve was opened and the
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vacuum lever was turned on.  Once the sample had reached the
end of the tube (1/8 inch OD, Teflon TFE tubing), the needle
valve was used to stop the flow, the feeding line was placed
back into the adaptor of the conditioned column and the
sample was processed.  The flowrate was established by
opening the needle valve and carefully adjusting the vacuum;
both the needle valve and vacuum can be used to achieve
finer adjustment of the flowrate once processing has begun.
Post-column effluent samples were taken after 100, 500,
750, 850 and 950 ml have passed through the column as shown
in Figure 3.3.  These were subjected to toxicity testing.
The EPA Phase II Draft Document suggests collecting post-
column effluent samples after 25, 500 and 950 ml have passed
(5).  However, additional samples were collected to obtain a
better indication of whether sorptive capacity of the column
was exceeded. Post-column effluent samples were taken by
carefully removing the stopper containing the column from
the vacuum flask (Figure 3.1), wrapping the piano wire
around the threads of the collection vial, placing the vial
under the luer tip, and inserting the vial and column back
into the flask.  No sample concentration was done following
passage through the column.
A.3  Elution of MeOH/H20 Fractions
Once the sample was passed through the column, the
MeOH/H20 elutions were repeated in the same manner as
described for the controls (Figure 3.2).  A set of eight, 5
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ml disposable syringes, each containing 3 ml of the required
percent MeOH/H20 mixtures (25, 50, 75, 80, 85, 90, 95, 100%)
with the addition of a 2 ml of headspace were inserted in
ascending order of percent MeOH/H20.
Figure 3.4 shows the extent of sample concentration
caused by the elution procedure and the subsequent dilution
required for toxicity testing.  By using 3 ml of each eluent
and 1 liter of sample, the concentration factor was 333X.
From each elution, 150 uL was diluted with 10 ml of dilution
water (a dilution of 66.7X) and tested for toxicity.  Thus,
the final concentration of the compounds to which the test
organisms were exposed was 5X that of the original sample.
However, this assumes that the elution process was 100
percent efficient and that each toxic compound had eluted
into one particular fraction.  Neither one of these
assumptions can be achieved experimentally.  Therefore, the
expected concentration of the eluted compounds should be
less than 5X.  It should also be noted that the final
percent MeOH at the point of toxicity testing varies between
0.375 to 1.5 percent for this elution series; keeping the
percent MeOH less than 1.5 was important so as to eliminate
MeOH toxicity.
Post-column effluents and MeOH/H20 elutions from the
column procedure were stored overnight in a refrigerator at
4°C and toxicity tests are conducted the next day.  The
glassware and tubing used during this process must be
thoroughly cleaned (see Appendix A for details) before the
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next sample can be tested.  A list of equipment and
materials used in the column elution procedure is given in
Appendix B.
B. Bioassay Procedure
Two types of bioassays were used to measure acute
toxicity during this research: a bioassay based on the
Ceriodaphnia C. dubia species and the Microtox (Microbics
Corp.) assay procedure.  The Ceriodaphnia can be described
as a small crustacean found typically in most surface water
sources in the United States.  It is part of the Cladocera
Order under the Phylum Arthropoda (13).  EPA has selected
this organism for testing based on many factors such as
sensitivity, availability and cost (14).  The Ceriodaphnia
are preferred over the more well-known Daphnia maqna and
Daphnia pulex because they are smaller in size, have shorter
generation times and are more sensitive.  Typically,
Ceriodaphnia can produce 3 to 4 broods per week under
optimal laboratory conditions (15).  A large number of  .
neonates are required to test for toxicity as outlined by
the TIE protocol, and the Ceriodaphnia are amenable to this
need.
The Microtox System uses a strain of marine
photoluminescent microorganisms that resemble photo-
bacterium phosphoreum (16).  These organisms emit light as a
by-product of respiration (17).  If something interferes or
inhibits respiration, a reduction or elimination of light
--- ͣ^^^^^i^^^^^n
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output is observed. The Microtox instrument has a
photomultiplier which is sensitive to this light emission.
A decrease in light output after the bacteria have been
exposed to a sample gives an indication of toxicity; the
effect is proportional to the amount of toxicity present.
C. Illustration of Procedure Used to Analyze Bioassay Data
The following hypothetical example is given to
illustrate the process of conducting a Ceriodaphnia toxicity
test.  Although, these data are not real, the results of
this research gave most of the patterns included here for
discussion.  The process begins with the Toxicity Request
Form (Appendix C) shown in Figure 3.5.  A composite sample
was taken at the Imaginary Creek WWTP in Example, North
Carolina, between the dates of 1/16/89 to 1/17/89.  The
sample was considered toxic by baseline tests taken on
1/18/89.  The C18 SPE Column elutions were conducted on
1/23/89. The Toxicity Request Form was filled out for the
post-column effluents (slanted lettering style) and given to
the bioassay laboratory.  This informs the bioassay
laboratory personnel of the in-coming samples and allows
them to prepare for testing the following day.  This usually
entails the isolation of adult test organisms, labeling
sample cups, filling out the top portions of the data
recording form (Figure 3.6) and preparing the dilution
water.
The samples were prepared for toxicity testing the next
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TOXICITY  TEST  REQUEST  FORM
Ceriodapnia  rinhia
NAME:   T.    CHAMPUN DATE: 1/23/89
LOG   #
CH1.0
CH1.1
CH1.2
CH1.4
cm.5
SAMPLE
DATE
SAMPLE  I.D.
I//6
1/ 6
1/ IE
l/IG
l/lfi
I/If;
CFEO _
LOCATION
RFI2
I
TREATMENT
DATE TIME
J/23:AK.17^ AM
ZZS AM-
AM
TYPE OF TEST: TIMED LETHALITY (10 mL; no dilutions)
TIMED LETHALITY (10 mL; w/ dilutions)
ACUTE STATIC (50 mL; 24 & 48 HR LC50)
7-DAY MINI CHRONIC (15 mL; reproductive)
OTHER (_________________________   )
SPECIAL INSTRUCTIONS: NONE
RESULTS:
LOG # CH1.0 CH1.1 CH1.2 CH1.3 CH1.4 CH1.5
_A ET50=  1.4   >48  > 4g  8,Q  8.0   3.2
_B LC50= _______________________________
C  CHRC=
(PASS/FAIL)
REQUEST RECEIVED BY:_
DATE: V23/89_______
V24/89
MJM
TEST DATES;
COMMENTS:
to   1/26/89
Figure 3.5 Toxicity Test Request Form
ͨ»1
m
&
(D
!?
rt
ft
•<
(D
0)
ft
O
rt
P)
o
ͨ1
?^
in
tr
(D
(D
rt
TIMED I.BTRALZTY TEST DATA / WOllKSIIEET
Ceriodaphnla dubla
SAMPLE I.D.; Imaginary   Creek WWTP ^ 1/16/89 to 1/17/89 Composite     NAME; T.ChampHn
SOURCE; Botany Pond/Fish Tank             LOT »;    15
pH;_____    D.O. ;SAT      Alk;_____   Hardness;_____   Cond;
CONTROL/DILUTIOW WATER
INITIAL:
Filter;GF/C • Temp;___
INITIAL
FINISH
DATE:
DATE:
1/24/89
1/26/89
TIME;
TIME:
0900
0900
ANALYST; MJM/TLC
ANALYST; MJM
TEST VOL;    10mis f ORGANISMS/CUP___5. DILUTIONS; none
ADULTS
ISOLATED
1355
AT;  1/^3
SAMPLE
REPLICATE
f  ORGANISMS
1      CF
A
5
eO
1      B
5
EFE
A
5
lOO
1    B
5
1     EFE
A
5
500
1    B
5
1    EFE
5
750
1    B
5
1    EFE
A
5
850
1    B
5
1   EFE
A
5
950     1
1    B
5
TIME:     NAME
0930     MJM OK Id OK OK OK OK OK OK OK Id OK OK
1000      MJM 2d2tw 2d3tw OK OK 9.^ 9^ OK Q^ ld 1d Id OK
1100      MJM 3d2tw 3d2tw OK OK Ok Ok OK \  OK 1d1tw !2d Itw 2d 1d1tw
1300     MJM 5d 5d OK OK !   OK OK Idltw 1d2tw 2d Itw 2d1tvy 3d Itw L^CJ
1700      TLC — — OK OK OK 9K 2d1tw 3d 3d2tw 2d2tw 4d 3d1tw
0300     MJM — — Id Itw Hw OK 3d Itw 3d Itw 5d 4d 1    5d 5d
0900     MJM _ — 2d1tw Idltw 1d2tw 1d2tw 5d 5d — 5d —
Temo   fCl
DH                             1 7.8 7.7 75 7.7 7.6 75 7b    1 7.B  1
DO       fma/L)   | 9.1   1 9.0  1 8.0 8.2   1 ^.1    1 8.0  1 8.2   1 8.1    1
COMMENTS: u
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day by removing them from the refrigerator and warming them
to 25°C in a water bath. The sample vials were then removed
and poured into the testing cups.  Replicated cups were
rinsed first with a small portion of sample and then 10 ml
of sample were poured into each cup.  Replicates were used
to ensure against the invalidation of the test from the
accidental loss of a cup.   The Timed Lethality Test was
performed using five neonates, born from the isolated adult
population from the previous day which were transferred to
each test cup.  The initiation of the toxicity test began
once the neonates were transferred.  Samples are not diluted
in the Timed Lethality Test; rather, mortality readings are
taken typically at 0.5, 1.0, 2.0, 4.0, 8.0, 24.0 and 48.0 hr
past the initial transfer.
Figure 3.6 shows the mortality readings as they were
obtained for this test.  Death was reported by the lower
case letter "d" and twitching by "tw".  Additionally, "er"
was used to indicate erratic characteristics shown by the
organisms behavior.  A complete description of the terms
used to describe the behavior of aquatic life can be found
in lERL-RTP Procedures (18).  After the 48 hr reading,
dissolved oxygen (DO) and pH measurements were conducted on
the test cups showing significant mortality.  This insured
that DO and pH were within acceptable limits for
Ceriodaphnia survival and thereby eliminating artifactual
mortality.
The mortality results were stored on Lotus 1-2-3 work
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sheets which can be used to generate tables such as shown in
Table 3.1.  The results of the replicated cups were combined
and reported in the cellular blocks on this form.  ET50 and
TTU values were determined and reported at the bottom of
each cell.  The ET50 value refers to the elapsed time
required for 50 percent mortality to occur.  It is
determined from a mortality versus log of elapsed time plot
as illustrated in Figure 3.7. Mathematically this is the
same as a linear interpolation based on a logarithmic scale.
The Time-based Toxicity Unit (TTU) was developed in this
research and is explained in Section III.D.  Its purpose was
to provide additional information regarding the progression
of toxicity over time.
The Standard Microtox procedure was followed exactly as
given in the Microbics Manual (17).  This procedure required
the bacterial reagent to be exposed to a sample dilution
series of 50, 25, 12.5 and 6.25 percent of the original
sample.  Light output measurements were taken of the reagent
before the sample was introduced.  As soon as the readings
were reported on the strip chart recorder, the bacteria were
exposed to the sample dilution series.  Light output
readings were taken at 5 minutes and 15 minutes to record
any reduction in light output.  Once testing was finished,
the data recorded on the strip chart was reduced using a
computer program developed by the Microbics Corporation or
by following the instructions in the Microtox manual (19).
The final results were reported in terms of an EC50 value.
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TIMED LETHALITY DATA / WORKSHEET
TESTS STARTED ON 1/2A/89
(NO MORTALITY IN THE CONTROLS)
IMAGINARY CREEK WUTP, EXAMPLE. NO
COMPOSITE SAMPLE 1/16/89 TO 1/17/89
FRACTIONATION SPE C-18 COLUMN
BIOASSAYS CONDUCTED IN
PLASTIC CUPS
cecsssssftsesxsssssasssEssrsssss Ksessssesssesrsssasscrssasscsss ss sBsrcssss
KssssBssrsassss:
1 TIME LAPSED LOG
1 HOURS TINE TIME
Ksacessssecssssssssa =s=r=sa:
1   900 0
1   930 0.50 -0.301
1  1000 1.00 0.000
1  1100 2.00 0.301
1  1300 4.00 0,602
1  1700 8.00 0.903
1   900 24.00 1.380
1   900 48.00 1.681
SAMPLE
01-16-CFEO
I I
I I
SAMPLE
01-16-EFE100 I I
Essssrassss
NUMBER  NUMBER PERCENT  | | NUMBER  NUMBER PERCENT
ORGANISMS DEAD MORTALITY | | ORGANISMS DEAD MORTALITY
s csrssssssassssassssss=ssss===
10     0 O.OX
10     1 10.0X
10     4 40.ox
10     6 60.0X
10    10 100.OX
10    10 100.OX
10    10 100.0X
10    10 100.OX I
ET50 « 1,4  TTU » 46.5X  | ET50 > 48
10 0 O.OX   1
10 0 o.ox     1
10 0 O.OX   1
10 0 O.OX   1
10 0 O.OX   1
10 0 O.OX   1
10 1 10.OX   1
10 3 30.OX   1
48 TTU = 1.7X   1
SAMPLE 1
01 16-EFE500 1
:srs=ss==s: ==s=as==s
NUMBER NUMBER PERCENT  |
ORGANISMS DEAD MORTALITY |
10 0 O.OX 1
10 0 O.OX 1
10 0 O.OX 1
10 0 O.OX 1
10 0 O.OX 1
10 0 O.OX 1
10 0 O.OX 1
10 2 20.OX 1
ET50 > 48 TTU s= 0.8X 1
cxessscsssssssBCSSSsssassssa BsecsxssasKassBSsrasasssesssa aaaecaaeaaaaeasaassaaas
aaaaaeaaaxaaaxasaasaaaaaaeaa m\
1 TIME LAPSED LOG
1 HOURS TIME TIME
essassassaaassaasaaasaraas
1   900 0
1   930 0.50 -0.301
1  1000 1.00 0.000
1  1100 2,00 0.301
1  1300 4,00 0.602
1  1700 8.00 0.903
1   900 24.00 1.380
1   900 48.00 1.681
aeaaaaaaaaasaaBasaaaaaaaaaaa:
SAMPLE
01-16-EFE750 |
lazaaaaeaaaKxaasaxeEaaaEaaaax
NUMeEft  NUMBER PERCENT  |
ORGANISMS DEAD MORTALITY
csaasaaeaaaaccaaeaasaas
aasaeaaaaaasaaaasaaas
I I SAMPLE
01-16-EFE850
I I
01
SAMPLE
16-EFE950
ͣsss«cs«acess=ssssszss&=srrs=3
I NUMBER  NUMBER PERCENT  |I ORGANISMS DEAD MORTALITY j
NUMBER  NUMBER PERCENT
ORGANISMS DEAD MORTALITY
ss «BSSSSas«SS£SSBKrsS=SSSS=SSS
10 0 O.OX
10 0 O.OX
10 0 O.OX
10 0 O.OX
10 2 20. ox
10 5 50.0X
10 6 60.0X
10 10 100.0X
= 8.0 TTU = 12.2X
aaasaiaa SEsas =aa==r=a=a
I    ETSO >
10 0 O.OX 1
10 10.OX 1
10 20.OX  1
10 30.OX  1
10 40.OX  1
10 50.OX  1
10 90.OX  1
10 10 100.0X 1
8.0 TTU = 28.2X  1 ET50 =
10 0 O.OX
10 0 O.OX
10 1 10.0X
10 3 30.0X
10 6 60, OX
10 7 70.OX
10 10 100.0X
10 10 100.OX
3.2 TTU = 25.6X
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Figure 3.7 Percent Mortality Versus the Log of Elapsed
Time for Hypothetical Samples (a) CFEO,
EFEIOO and EFE500 and (b) EFE750, EFE850 and
EFE950.
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This value represents the effective concentration at which
50 percent of the light output capability of the bacteria
has been reduced.  A quick-reference guide for the Microtox
procedure is given in Appendix D of this report.
D. The Time-based Toxicity Unit (TTU)
The results of toxicity testing can be expressed in
Toxic Units (TU) to obtain a direct relationship between the
reported values of mortality and toxicity.  The TU value is
a measure of the strength of a chemical expressed as a
fraction or proportion of its lethal threshold concentration
(20).  The strength may be calculated as shown in the
following equation:
TU = ________concentration of toxic compound________
lethal threshold concentration of toxic compound
A TU value greater than 1.0 would represent mortality of
more than 50 percent of the test organisms, while a value
less than 1.0 would indicate less than 50 percent mortality.
A TU value of exactly 1.0 would indicate lethality of 50
percent of the organisms.  Higher values are assigned to
higher degrees of toxicity establishing a direct
relationship.
A TU was developed from the timed lethality (ET50) data
to facilitate comparisons of samples before and after C18
column passage and to provide better data interpretation.
ET50 values, or the time required to observe 50 percent
(.
mortality of the test organisms, establishes an inverse
relationship between the degree of toxicity and the reported
value.  For example an ET50 value of 2 hr is considered to
be significantly more toxic than an ET50 value of 8 hr.  An
inverse relationship is awkward to use when trying to
illustrate graphically the reductions in toxicity due to
sample treatments in the TIE protocol (Figure 2.4).  In
addition, the ET50 provides no information on the
progression of toxicity with time.  The following Time-based
Toxicity Unit (TTU) was developed to overcome these
disadvantages:
I Mtlog(t+l)
TTU = --------------------- X 100%     Eq. (1)
t \ "max
log(t+l)
y_^
/  log(t+]
where M^ represents the number of mortalities observed at
time t, and VL^^^  refers to the maximum number of mortalities
which could possibly be observed at time t.  The value of
'Vax ^^ ^^® total number of test organisms.  A TTU of lOO
percent would represent the observance of complete mortality
at the first reading (i.e., M^ = Mjjj^jj ) and subsequently all
other readings.  A TTU value of zero percent would indicate
the observance of no mortality over the duration of the
test.
The TTU expression (Eq. 1) establishes a direct
relationship between the intensity of toxicity and the
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reporting of toxicity.  This unit is not unique; other
schemes are possible.  It was created primarily to present
the results of the ET50 tests in graphical form so that the
larger the value of the plotting point, the greater the
toxicity.  The reciprocal of elapsed time provides a
weighting scheme which places emphasis on the initial
readings.  That is, mortalities observed in the early stages
of testing indicate more significant toxicity than those
occurring later.  A logarithmic time scale allows for the
weighting to be expressed over two orders of magnitude to
accommodate observations taken from 1 to 48 hr; an
arithmetic time scale would have placed too little
significance on mortality observed at 24 and 48.  Use of
log(t+l) rather than log{t) avoids taking the log of a
number less than or equal to one, which would cause a
negative or zero value to be calculated at the 0.5 and 1.0
hr readings, respectively.
E. Illustration of Use of TTU Concept
The hypothetical mortality data of one sample, given in
Table 3.1, are expressed in terms of TTU values in Table
3.2.
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Table 3.2
Example Calculation of Time-based Toxicity Unit
for Imaginary Creek WHTP,Example, NC, Sample CFEO
Elapsed
Time(t)
1 Observed
Mortality M^
Mt *Vax
log(t+l) log(t+l) log(t+l)
0.5 5.6 1 5.6 56.0
1.0 3.3 4 13.2 33.0
2.0 2.1 6 12.6 21.0
4.0 1.4 10 14.0 14.0
8.0 1.0 10 10.0 10.0
24.0 0.7 10 7.0 7.0
48.0 0.6 10 ^    6.0 6.0
TOTALS: 68.4 147.0
b     _. I Mtlog(t+l) 68.4TTU =-----------------X 100%  =  147.0   X 100%
I Mmaxlog(t+l)
TTU =  46.5%
The TTUs for the other samples were calculated in a similar
manner and presented along with their corresponding ET50
values in the lower portion of Table 3.1.
Table 3.3 compares the ET50 and TTU values for the C18
post-column effluent samples and illustrates the advantages
of the TTU.
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Table 3.3
A comparison of ET50 and TTU Values for the C18 Column
Effluent Results from the Imaginary Creek WWTP,Example,NC
TTU{%)
46.5
1.7
0.8
12.2
28.2
25.6
Sample ET50(hr)
Identification
CFEO 1.4
EFEIOO >48
EFE500 >48
EFE750 8.0
EFE850 8.0
EFE950 3.2
Samples EFEIOO and 500 both have ET50 values greater
than 48 hr, yet the data shown in Table 3.1 reveal that
mortality was actually observed in both of these samples.
In contrast, toxicity values can be assigned to these
samples using the TTU approach even though mortality was
less than 50 percent after 48 hr.  These TTU values (1.7 and
0.8) are small, however, because mortality observed in the
later stages of testing is not very important on this
toxicity scale.  Thus, the weighting scheme devised for time
at which mortality occurs provides additional information
about the expression of toxicity in the sample.
The TTU approach can also distinguish between toxicity
in two samples with the same ET50 but different time
progressions of toxicity.  For example, Table 3.3 shows that
samples EFE750 and 850 have identical ET50 values (8 hr).
However, their corresponding TTU values are significantly
different.  Figure 3.7b shows that while there two samples
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reach 50 percent mortality in 8 hr, the time progression of
mortality is different; i.e., mortality begins two readings
earlier for the EFE850 sample.  This would imply that sample
EFE850 should be more toxic because mortality was observed
sooner in the test.  The weighting scheme of the TTU assigns
more significance to death in the earlier stages of testing
and, therefore, would assign a higher TTU value to EFE850.
The TTU can also result in comparisons of toxicity
between two samples that are opposite to those based on
ET50.  This is illustrated by samples EFE850 and 950.  The
ET50 values for EFE850 and EFE950 are 8 and 3.2 hr,
respectively.  However, the corresponding TTU values
indicate the reverse ordering.  Figure 3.7b shows that the
progression of mortality begins earlier and is faster in the
initial stages of testing for sample EFE850.  It is not
until the 2 hr reading that more mortality occurs in sample
EFE950.  Thus, the time-weighting factor again assigns more
importance to mortality occurring in the initial stages of
testing and produces a higher TTU for EFE850 even though 50
percent mortality occurs earlier in the EFE950 sample.
Figure 3.8 is a graphic representation of the TTU
values obtained from the data of the hypothetical example.
The ability of the CIS column to retain the toxic compounds
is seen by comparing toxicity of the sample before passing
it through the column (BEFORE COLUMN) and samples collected
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COLUMN   EFFLUENTS   FOR   IMAGINARY  WWTP
1/ie/a» TO   1/17/BB  COMPOSFTE SAMPtrS
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VOLUME PASSED (mis)
•50
Figure 3.8 Composite Sample 1/16 to 1/17/89, Imaginary
Creek WWTP, Example, NO (a) Post-Column
Effluents.
after passage. The initial volume passed has no toxicity
remaining.  However, toxicity increases as more sample is
passed thus indicating that the sorptive capacity of the 018
column has been exceeded. Reducing the volume passed from
one liter to 500 ml would most likely alleviate this
problem.
Bar graphs of the TTU values will always be presented
using a 0 to 100 percent scale as shown in Figure 3.8.  This
gives the proper qualitative perspective of toxicity from
sample to sample and for the various percent MeOH/H20
fractions.  The intent of such bar graphs is to illustrate
the efficiency of the column in retaining toxic compounds
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and in segregating them into different fractions.
F.  Target Compound Selection
Phenol (Ph), 1-methylnaphthalene (MN), nonyl phenol
ethoxylate 9 mole (NPE) and di-n-octyl phthlate (DOP) were
selected to determine if the C18 SPE Column provides an
accurate means of detecting their presence.  The selection
criteria were:
1. wide representation of log octanol/water
partitioning coefficients,
2. acute toxicity to Ceriodaphnia at reasonably
attainable concentrations and
3. a concern at Highpoint Westside WWTP in North
Carolina, a case study in this research, or at
POTWs in general.
Table 3.4 is a summary of the physical and chemical
properties of these four compounds.
The octanol/water partition coefficient (Kow) is the
ratio of a chemical's concentration in the octanol phase to
its concentration in the aqueous phase in a two-phase
system.  Ph and DOP were selected because they gave a very
wide range of log Kow values (1.46 to 9.2).  Such a wide
range was necessary to determine if a direct relationship
exists between increasing log Kow (i.e.,increasing non-polar
nature) and elution in increasing percent MeOH/H20 fraction.
These compounds were selected to represent the ends of the
partitioning coefficient scale. Ph is acutely toxic to
Ceriodaphnia at a lethal concentration in which 50 percent
(LC50) mortality is observed after a 48 hr period of 4.3
Table 3.4
Target Compounds
Sumnary of Physical and Chetnical Properties
Phenol
(Ph)
1-Methylnaphthalene
(HM)
Nonylphenol
Ethoxylate 9 nole
(NPE)
Di-n-octyl
Phthalate
(OOP)
Chemical
Formula
Chemical
Structure
Molecular
Weight
h\° CfgN^CNj ^jsho^io ^Z4'^3(P^
94.11 gm/mole (26)
log Octanol/Uater (Observed)     1.46 (26)
Partition Coefficient (Estimated) 1.46 (27)
Density
Solubility
Vapor Pressure
pica
LCSO Value
1.071 gm/cfflS (26)
93,000 mg/L a 2S C (26)
0.5293 torr (26)
10.02 (26)
4.3 mg/L B 24 C (21)
QO
142.2 gm/mole (22)
3.9 (24)
3.84 (27)
1.0202 gm/cffl3 (22}
0(CHjCH20),H
ll-CH-CH2-CH-CH2-CM-CH^
CH ^        CH3        CHo
616.4 gm/mole (25)
7.8 (28)
1.057 gm/cniS (2S)
C-0-C^H„
C-0-C,H,^
391.0 gm/mole (26)
9.2 (26)
9.53 (27)
0.982 gm/cfflS (26)
3 mg/L 8 25 C (26)
< 0.2 torr a ISO C (26)
1.42 mg/L (21) 5.5 mg/L (23) 0.32 mg/L (*•)
(•*) MOEC Reproduction of Oaphnfa magna (21)
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mg/L.  Ph has also been identified as one of the compounds
discharged from the Highpoint Westside WWTP (21).  There
were no lethal concentrations values found for DOP.
However, a no-effect concentration value (NOEC) was located
for the reproduction of Daphnia maqna at 0.32 mg/L.  DOP has
been identified in the influent stream of the Highpoint
Westside WWTP (21).
MN was selected because its log Kow is 3.9, thus being
between Ph and DOP (24). MN is acutely toxic to
Ceriodaphnia (LC50 value of 1.42 mg/L), and it has been
identified in both the influent and effluent of the
Highpoint Westside WWTP.
NPE is an all purpose detergent and wetting agent used
for its good dispersing and emulsifying qualities (25).
This compound was chosen because it is presently being used
by industries at Highpoint, is acutely toxic to Ceriodaphnia
(LC50 = 5.5 mg/L), and generally represents an important
class of pollutants (surfactants) in municipal wastewater
treatment. The log Kow is suspected to be greater than the
reported value for MN.  However, no value was found in the
standardly used compendium of log Kow (26, 27, 28).
Therefore , only an estimate could be made.  The value of
7.8 reported in the summary table was determined using a
linear regressed equation which relates log Kow with density
values (28).  This value should be viewed as a crude
estimate.  Additionally, a value of 15.9 was determined from
a linear relationship between log Kow and molecular weight
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(28).  Structural fragment addition led to a log Kow value
of -7.35 (27).  There was no measured value found in the
literature.  The calculations used to determine log Kow
estimations for all of the target compounds are shown in
Appendix E.
G. Selection of WWTPs for TIE
Secondary effluents from the Westside WWTP in
Highpoint, North Carolina and the Cross Creek WWTP in
Fayetteville, North Carolina were tested using the
procedures outlined in Phase I (Toxicity Characterization
Procedures) of the TIE protocol.  Additionally, Phase II
(Toxicity Identification Procedures) C18 column elutions
were conducted on samples which indicated a reduction in
toxicity after passage through the CIS Column.
A flow diagram of the Westside WWTP at Highpoint is
given in Figure 3.9.  Biological treatment consists of a
trickling filter and activated sludge system operating in
series.  The detention time in activated sludge treatment is
about 14 hr, providing for excellent nitrification.  The
design flow rate is 6.2 MGD.  Before discharging into Rich
Fork Creek, the effluent is passed through a tertiary
filter. About 15 industries, including metal platers and
finishers, oil manufacturing, textiles, organic chemical
manufacturing, and drum cleaning, discharge their wastewater
to this plant; these comprise about 12% of the flow.  The
effluent stream from the treatment facility is approximately
^ ͣ>
/ TRICKLING    \
FILTER
ANAERO
SLUDGE
DIGEST.
SLUDGE
THICK WESTSIDE
WWTP
CHLORINE
BASIN
AERATION   BASIN
FINAL
CLARIFIERS
EFFLUENT
FILTER
PRIMARY
CLARIFIERS
LEGEND:
INFLUENT
PUMP STA.
RICH
FORK CREEK
LIQUID
------SLUDGE
Figure 3.9 Schematic of Westside Wastewater Treatment
Plant, Highpoint, NC
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95 percent of the total stream flow expected during a 7Q10
low flow period.  Thus, the State of North Carolina has
imposed strict biomonitoring requirements.  A more complete
description of the treatment facility and operational
characteristics is given by Storm, DiGiano, and Christman
(21).
A flow diagram for the Fayetteville - Cross Creek WWTP
is given in Figure 3.10.  The treatment processes consist of
a pure oxygen activated sludge process, clarifiers and post
instream chlorination in series (29).  There is no primary
clarification before aeration and the tertiary filters as
well as the sludge drying beds are not in use.  The
detention time in the activated sludge process is only 2 hr
which means that no nitrification occurs.  Fayetteville,
Mills and the Town of Hope are the major domestic sources
contributing wastewater to this facility. Approximately 10
percent of the facility's total design flow (16 MGD) is
considered industrial waste by volume.  Typical industrial
sources contributing wastes to the facility are organic
chemical manufacturing, textiles, metal platters and
finishers, oil manufacturing and a large tire manufacturer.
The instream waste concentration (IWC) is 3.58 percent based
on the 7Q low flow period for the Cape Fear River (29).
Because the IWC is very low, the effluent is diluted
sufficiently to allow the Cross Creek WWTP to pass the State
of North Carolina biomonitoring requirements for acute
toxicity.  However, this plant still fails to meet limits
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Figure  3.10 Schematic of Fayetteville - Cross Creek
Wastewater Treatment Plant,   Fayetteville,  NC
55
set for chronic toxicity.
IV.  EXPERIMENTAL RESULTS
A.  Background Toxicity Sources
A.l Evaluation of Methanol (MeOH)
While MeOH was chosen by EPA to be the appropriate
solvent for the C18 SPE column elutions, it is known to
cause acute toxicity to Ceriodaphnia at fairly low
concentrations.  In the January 1987 draft of Phase I,
Toxicity Characterization Procedures (14) and subsequently
in the City of Largo Evaluation (11) and in the Las Vegas
Report (12), 2.0 percent MeOH was reported as the
concentration at which no mortality was observed over a
48 hr duration.  Before proceeding with this study, it was
deemed important to confirm that dilution of MeOH/water
fractions to 2 percent MeOH would not cause background
toxicity.
Early results suggested that 2 percent MeOH was not
toxic. However, continual blank testing through the target
compound evaluation indicated sporadic toxicity.  The LC50
of MeOH was repeatedly tested during this research as
illustrated in Table 4.1. The results confirm the suspicion
of significant toxicity at about 2 percent.
57
Table 4.1
Methanol Control Testing
Date LC50 VALUE(30) 95% Confidence
4/27/88 2.9% 2.6 to 3.3
A:/21/BB 2.9% 2.6 to 3.3
4/27/88 2.9% 2.6 to 3.3
4/27/88 2.4% 2.1 to 2.7
7/19/88 2.0% 1.5 to 2.5
7/22/88 2.0% 1.9 to 2.0
Personal contact with Dr. Mount of U.S./EPA Duluth
Laboratory (31) confirmed these results; MeOH contamination
by either the manufacturer's distillation process or
laboratory use were suggested as causes.  Dr. Mount
recommended decreasing the MeOH percentage to 1.5 to avoid
such problems.
Even after adopting 1.5 percent MeOH, some mortality
was noted within a 48 hr period.  This was accounted for as
"background toxicity" and subtracted from total toxicity of
the sample through use of the Time-based Toxicity Unit
(TTU).
A.2 Effect of Bioassay Cup Material on MeOH Toxicity
Results
The results of MeOH bioassays using plastic and glass
cups are presented in Figures 4.1a and b, respectively.  The
raw data are given in Table D.l of Appendix F.  Figure 4.1a
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shows mortality occurred between 1.5 to 2.0 percent MeOH
whereas Figure 4.1b shows mortality at even lower percent
MeOH (it should be noted that bioassays were conducted in 10
ml glass beaker, as opposed to a 30 ml plastic cups).  These
results suggested that the Ceriodaphnia experienced a higher
degree of sensitivity to the MeOH when the test was
conducted in glass.  No reason was determined for this
result.
A.3  Toxicity of MeOH/HjO Eluents from the C18 Column
The toxicity of MeOH/HjO eluents from the C18 column
were tested as outlined by the procedures given in section
IIIA.  These MeOH/HjO solutions served as controls to check
the possibility of MeOH reacting with the C18 sorbent to
elute compounds that may cause toxicity to Ceriodaphnia.  As
mentioned in the CIS SPE procedure, the MeOH/H20 solutions
(25, 50, 75, 80, 85, 90, 95, 100 % MeOH/H20) were introduced
to the column prior to the sample in each experiment.
Figures 4.2a, b and c illustrate the toxicity of these
eluents (after required dilution) using plastic (Figure 4.1a
and c) and glass (Figure 4.2b) bioassay cups.  The raw data
are given in Table D.2 and Table D.3 of Appendix F.  All
three figures show that mortality existed at 1.5% MeOH.
Figure 4.2 shows that more mortality was observed using
glass rather than plastic cups which is consistent with
results of MeOH control testing presented in Figures 4.1a
and b.
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A.4  Toxicity of Diluent Water
Because the target compounds were added to diluent
water, a control study was needed to insure that the diluent
was not causing toxicity either in the samples passed
through the column or in the elution of the column with
MeOH/HjO.  The two diluents used in the evaluation of the
target compounds were "non-toxic" effluent from the Westside
WWTP at Highpoint, North Carolina and natural water from
Botany Pond in Chapel Hill, North Carolina.  The phrase
"non-toxic" effluent refers to wastewater samples that were
determined not to cause mortality of the Ceriodaphnia after
a 48 hr period.
Figure 4.3 illustrates the results of passing "non¬
toxic" effluent through a C18 column and subseguently
eluting it with various MeOH/H20 fractions.  No toxicity was
found in this diluent sample before introduction to the
column (see BEFORE COLUMN in Figure 4.3a).  The slight
amount of toxicity found in the post-column effluent sample
taken after 850 ml of the diluent had passed may have been
caused by contamination of the collection vial or retention
of the MeOH used during the conditioning of the column; this
is not considered a serious problem.  The toxicity of
Me0H/H2O fractions eluted from the column after passage of
the Westside WWTP diluent is presented in Figures 4.3b
(plastic cups) and 4.3c (glass beakers).  The 95 and 100
percent MeOH/H20 fractions were slightly toxic, a result
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typically associated with the higher percent MeOH/H20
fractions.  The final percent MeOH for conducting the
bioassays from these fractions were 1.43 and 1.5,
respectively.  These are close to the percentage where
toxicity due to MeOH itself is found.
A comparison of Figure 4.3b and c shows that more
toxicity was eluted when glass rather than plastic cups were
used for the bioassay; this is again consistent with earlier
control experiments.  The small toxicity peak at 75 percent
MeOH in Figure 4.3 (c) is also of interest.  This may be due
to the concentration of sublethal compounds; a result which
in theory is possible and is noted by EPA in their Phase II
Toxicity Characterization Procedures (5).  Chemical specific
analyses were not conducted to verify this possibility.
The toxicity of the other diluent used - Botany Pond
water - is given by Figure 4.4.  These results can be
compared directly to those in Figure 4.3 for "non-toxic"
Westside WWTP effluent as the diluent.  No toxicity was
found before passage through the column (see BEFORE COLUMN
in Figure 4.4a) and very little was observed in samples
collected after passage (see 500 and 850 ml post-column
effluent samples in Figure 4.4b).  The only toxicity noted
during MeOH/H20 elution was found in the 95 and 100 percent
Me0H/H20 fractions (Figure 4.4b).  As noted before, this
artifactual toxicity appears unavoidable and was probably
due to MeOH rather than diluent toxicity.  It is subtracted
from the toxicity measured for the target compounds are
64
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tested.
B.  Evaluation of Target Compound Toxicity
B.l  Phenol (Ph)
Concentration Tested: 43 mg/L
Figure 4.5a shows the results of passing a Ph solution
(43 mg/L) prepared with Botany Pond water, through a C18
column.  Ph was not retained by the CIS column.  If it was
retained, toxicity present before passage would have been
removed by the column.  Instead, all post-column effluent
samples contained toxicity equal to that of the feed to the
column.  The absence of toxicity in the eluted fractions
(Figure 4.5b) further reinforces this point.  The Ph
solution had a measured pH of 7.8, approximately two log
units lower than the reported pKa for Ph of 10.02 (25) or
9.9 (32).  Thus, Ph was at least 99% in its uncharged form,
which theoretically should favor removal by non-polar
interactions between Ph and the sorbent.
The Phase I Toxicity Characterization Procedures for
the C18 column included adjusting sample pH to 3 and 9
before passage (see Section IIB). However, no retention of
Ph toxicity occurred at either pH value (Figure 4.6a).
Further confirmation of lack of Ph retention was obtained by
absorbance measurements (268 nm) of the solution, before and
after the column (Figure 4.6b).  Figure 4.6b does show a
slight decrease in absorbance at pH 3 after 25 ml have
passed; however, this was not supported by corresponding
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toxicity measurements (Figure 4.6a).  The C18 column would
appear to be unable to retain Ph from the spiked solution.
Two alternative explanations are possible for failure
of the CIS SPE Column to retain Ph.  The first centers
around the low Kow (log Kow of 1.46), and high water
solubility (93,000 mg/L at 25°C (26)) of Ph. Both indicate
relatively high polarity and suggest that Ph should not be
retained by a non-polar sorbent.  The second explanation
involves the conditions used for operating the CIS SPE
Column.  The flow rate (5 ml/min) and volume (1 Liter) of
sample used by SPE to concentrate organic toxicants from
dilute aqueous samples is considerably greater than the
flowrate (0.02 ml/min) and volume (microliters) used in HPLC
column work.  This may explain why CIS HPLC Columns are able
to retain Ph, while CIS SPE Columns are not.  At the volume
and flowrate used for SPE, Ph may be retained momentarily
and then subsequently eluted back into the aqueous mobile
phase.
B.2  1-Methylnaphthalene (MN)
Concentrations Tested: 2.9, 7.1, 35.5 mg/L
Because MN was the first target compound to be tested,
the toxicity artifact caused by 2.0 percent MeOH had not
been realized before experiments began.  It was therefore
necessary to modify the procedure outlined in the preceding
section (Section IIIA.3) to maintain a maximum of 1.5
percent MeOH in the bioassay.  Instead of conducting another
series of C18 column tests (based on 1.5% MeOH) and
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generating new elutions, 150 ul of each MeOH/HjO eluent
(based on the original 2.0% MeOH) was diluted with 10 ml of
dilution water.  This modification insured a maximum of 1.5
percent MeOH and a concentration factor of 3.75X at the
point of bioassay testing.  The only significant change from
the original procedure is a concentration factor of 3.75X
instead of the usual 5X.  The results indicate no
appreciable loss in toxicity even though the concentration
factor had been decreased.
The C18 column test was performed using three different
MN concentrations (2.9, 7.1, 35.5 mg/L).  Figure 4.7a shows
an increase in toxicity with increasing concentration as
expected (see BEFORE COLUMN results), and no significant
breakthrough of toxicity with passage of up to IL of sample,
even at the highest feed concentration.  MeOH/H20 elutions,
using plastic (Figure 4.7b) and glass (Figure 4.7c) both
showed that the 80 percent MeOH/H20 fraction contained most
of the toxicity, regardless of the MN concentration
introduced to the column.  The recovery of toxicity from
these three different feed concentrations of MN is also
consistent, i.e., the TTU value for the 80 percent MeOH/H20
fraction is highest for the highest feed concentration.  As
noted before, the column elutions conducted in plastic cups
seem to attenuate toxicity to Ceriodaphnia when compared to
results using glass. MN was the only target compound tested
in plastic and glass; the bioassays for the other compounds
were conducted in plastic cups as outlined by the standard
70
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procedure (section IIIC).
A comparison of Ceriodaphnia and Microtox bioassay of
column elutions is presented in Figure 4.8.  The feed
concentration of MN selected for this study was 7.1 mg/L,
the second highest concentration presented in Figure 4.7.
When the Ceriodaphnia test was conducted in plastic cups
(Figure 4.8a), no toxicity was recovered in the 80 percent
MeOH/HjO fraction.  A similar result was repeated at this
same MN feed concentration (Figure 4.8b).  Toxicity in the
higher MeOH/H20 fractions (90 and 95%) was due either to the
additive effects between MeOH and MN or due to MeOH alone.
However, the Microtox bioassay procedure was capable of
showing the 80 percent toxicity peak (Figure 4.8c) that had
not been observed using the standard Ceriodaphnia test
(Figure 4.8a) conducted in plastic cups.  Therefore, these
results of MN suggest Microtox to be more sensitive than the
Ceriodaphnia bioassay procedure when plastic cups were used.
Comparing results in Figure 4.8a and Figure 4.8b again
confirmed that glass increases the sensitivity of the
Ceriodaphnia bioassay.  Comparison of Figure 4.8b and c
therefore , shows a similar response of the two bioassay
procedures in recovery of toxicity in the 80 percent
MeOH/H20 fraction.
B.3 Nonylphenol Ethoxylate 9 Mole (NPE)
Concentrations Tested: 11, 27.5, 55 mg/L
The feed concentrations of NPE through the C18 column
were 11, 27.5, 55 mg/L.  Figure 4.9a demonstrates that all
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three solutions had significant initial toxicity (see BEFORE
COLUMN results) which was in all cases retained completely
by the C18 sorbent.  Figure 4.9b shows that feed
concentration produced some variability in the location of
MeOH/H20 fraction that eluted most of the toxicity.  At the
lowest concentration (11 mg/L), the 85 percent MeOH/H20
fraction was only slightly more toxic than the 80 percent
MeOH/H20 fraction whereas the highest concentration (55
^g/L)I   it was the reverse ordering.  The important point
(shown by Figure 4.9b) is that the elution procedure of the
C18 column was unable to isolate cleanly the toxicity due to
a single known compound into one MeOH/HjO fraction.
Instead, toxicity peaked in the 80 to 85 percent MeOH/H20
fractions.
B.4 Di-n-octyl Phthalate (DOP)
Concentrations Tested: 164, 491, 1473 mg/L
Toxicity testing of DOP indicated that a higher
concentration was required to produce significant mortality
than was originally expected; the 48 hr LC50 was determined
in-house to be 90 mg/L.  Despite having to use very high
concentrations (far greater than the solubility of DOP in
water of 3 mg/L at 25°C) as feed to the C18 column and risk
the possibility of exhaustion of sorptive capacity, testing
was continued because DOP is representative of very non-
polar compounds (log Kow > 9) in contrast to Ph and MN.
Early breakthrough of DOP occurred in the C18 column
effluent.  As shown by Figure 4.10a, the TTU values of the
74
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post-column effluent samples are similar to those of the
feed.  The feed solutions of DOP were probably not true
solutions and this may have affected the TTU pattern
observed in the effluent samples.  The lowest concentration
(164 mg/L) was milky white whereas the other two
concentrations (491 and 1473 mg/L) appeared to contain
minute droplets in suspension; these latter solutions were
composed of two distinct, liquid phases.  This problem is
obviously due to the DOP concentrations required for a
lethal response being far in excess of the solubility of DOP
(3 mg/L at 25°C) in water.  The concentrations of DOP used
for testing would be unlikely in the discharge of municipal
WWTP.  However, industrial sources may on occasion discharge
this compound into the collection system of POTWs in the
concentration range tested here; these tests should indicate
possible results of industrial effluent fractionation.
Despite breakthrough of the C18 column by DOP, it was
still possible to examine the MeOH/H20 elution results to
determine which fraction(s) contained the most toxicity.
Figure 4.10b shows extensive smearing of toxicity into
fractions ranging from 75 to 95 percent MeOH/HjO.
A comparison of elution toxicity (Figure 4.10b) and
presence of DOP in each fraction, as measured by absorbance
at 420 nm (Figure 4.10c) is shown.  Absorbance was used here
rather than concentration because MeOH had a pronounced
effect on the slope of standard concentration versus
absorbance curve. Therefore the presence of DOP in
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different MeOH/H20 fractions cannot be determined precisely
owing to varying degrees of MeOH interferences. A rough
correlation was observed between toxicity and absorbance in
each MeOH/H20 elution.  This gives some support to the idea
that the toxicity expressed by each eluted fraction is, in
fact, due to the presence of DOP in that fraction and
possibly indicates a correlation between toxicity and
concentration; such a correlation is one of the objectives
considered in EPA's Phase III Toxicity Confirmation
Procedures.
Finally, the Microtox bioassay procedure was also used
on the MeOH/H20 elutions of the C18 column receiving the
highest DOP concentration (1473 mg/L).  The results are
compared to those using Ceriodaphnia bioassay in Figure
4.11.  The Microtox bioassay was unable to measure toxicity
in the 95 percent MeOH/H20 fraction (Figure 4.11b) which the
Ceriodaphnia had shown to be the most toxic fraction (Figure
4.11a).  If Microtox had been the only bioassay procedure
conducted, the 95 percent toxicity peak would not have been
identified.  The Microtox procedure was repeated three times
on the 90, 95 and 100 percent MeOH/H20 fractions to
determine if experimental error could be responsible.
However in all cases, no noticeable toxicity was found.
Additionally, the standard color correction test recommended
by Microbics (19) for colored samples was conducted, but it
did not change the results.
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B.5 Summary of Target Compound Evaluation.
Table 4.2 summarizes the results from the target
compound evaluation.  This table shows the comparison of log
Kow values and the percent MeOH/H20 fraction for which
toxicity peaked for the different target compounds tested.
Theoretically, a correlation between increasing MeOH/H20
percentages and increasing log Kow values should exist.  A
compound with a low log Kow, if retained by the column,
should be removed in a lower percent MeOH/H20 fraction due
to its relatively high polarity and hydrophilic nature.  As
the log Kow values increase, a decrease in polarity or
increase in non-polarity is indicated and compounds become
increasingly hydrophobic.  These compounds would require a
higher percentage of MeOH/H20 before eluting from the column
sorbent.
Although only four target compounds were evaluated,
there is some broad indication of a relationship between log
Kow and percent MeOH/HjO (Table 4.2).  However, the
separation of these compounds is not well defined or
established in any particular fraction.  In the Patapsco
study (conducted in Baltimore, Maryland), the class of
compounds present in the 85 to 90 percent MeOH/H20 fractions
was determined to have a range of log Kow values between 3.6
and 9 (9).  In this study, all three target compounds (MN,
NPE, DO?) retained by the C18 column produced toxicity in
the 75 to 90 percent MeOH/H20 fractions.  Experimentally, it
would seem reasonable that mixtures of these compounds at
Table 4.2
flHMary of Target Compound Evaluation
Results
Target log ICow MeON/mter Fraction to Peak Toxicity
Compound Obaerved Estimated Cerlodaphnia Microtox
Phenol 1.46 (26) 1.46 (27) Not Retained Not Tested
(Ph)
1-Methylnaphthalana 3.9 (24) 3.84 (27) 8W SOX
(MN)
Nonylpttenol ........ 7.8 (28) SOX to 85X        Not Datectad
Ethoxytate 9 molo
(MPE)
01-n-Octyt 9.2 (26) 9.S3 (27) 95X S5X
Phthalate
(DOP)
03
O
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varying concentrations could elicit toxicity peaks ranging
between 75 and 95 percent MeOH/H20.  This possibly verifies
the wide range of log Kow values found in the Patapsco
fractions, and also shows the column's inability to separate
classes of compounds (as defined by a broad range of log
Kows values tested here) into more distinct fractions.
B.6 Summary of Microtox and Ceriodaphnia Comparisons
Table 4.3 shows the comparison between the Ceriodaphnia
and Microtox assay procedure based on LC50 and EC50 values,
respectively.  As indicated by Table 4.3, Microtox is less
sensitive than the standard Ceriodaphnia bioassay test
(conducted in plastic cups).  These results were expected
due to the physiological differences and contact-response
time between Microtox (marine bacterium) and the
Ceriodaphnia (a small crustacean).  The Ceriodaphnia are
capable of digesting soluble as well as insoluble forms of
compounds while the marine bacterium is restricted to the
soluble form.  Toxicants associated with colloidal particles
in water can be digested by the Ceriodaphnia causing a toxic
response while not effecting the marine bacteria.  This
difference in nutrient uptake between these two test
organisms is sufficient to cause a difference in
sensitivity.
The advantage of the Microtox bioassay procedure is a
fast response time.  Wastewater samples can be determined to
Table 4.3
Comparison Between
the Cerlodaphnia LCSO and the Microtox ECSO
for Selected Compounds
Chemical
Analyzed
Median Lethal Concentration (LCSO)
Cerlodaphnia (30)
Median Effective Concentration (ECSO)
Microtox (19)
Phenol
(Ph)
LCSO * 10.3 mg/L
95X Confidence (7.7 to 14.2)
ECSO -41.5 ng/L
9SX Confidence (18.6 to 92.8)
R « 0.99093
l-Nethylnaphthali
(MM)
LCSO ͣ 4.7 aig/L
95X Confidence (3.5 to 6.3)
ECSO > 8.4 mg/L
9SX Confidence (1.1 to 63.2)
R - 0.9S366
Nonylphenol
Ethoxylate
9 mole (NPE)
LCSO ͣ 6.7 mg/L
9SX Confidence (5.2 to 8.7)
ECSO > 275 mg/L
Dl-n-Octyl
Phthalate
(OOP)
LCSO ͣ 89.7 mg/L
9SX Confidence (74.1 to 106.7)
ECSO ͣ 262 mg/L
95X Confidence (1S3 to 448)
R « 0.97527
Methanol
(MeOH)
LCSO - 2.0X
95X Confidence (1.9 to 2.0)
ECSO ͣ3. IX
95X Confidence (2.S to 4.0)
R = 0.99869
CO
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be toxic within typically 20 minutes as opposed to the 48 hr
required by the standard Ceriodaphnia test.  This so-called
"quick response" is obviously not without a loss sensitivity
(see Table 4.3).  However, the cost of conducting the TIE
procedures and setting up the bioassays makes this "quick
response" a possible savings in time and money.  Microtox
can be effectively used to screen toxic from non-toxic
samples.  Samples that are determined to be toxic by
Microtox are typically very toxic to the Ceriodaphnia and
this determination within 20 minutes allows for samples to
be processed even sooner than if the baseline toxicity test
(24 hr) had been determined by the Ceriodaphnia.  This
"quick response" is crucial when dealing with samples that
show toxicity degrading rapidly over time.
C.  Evaluation of Toxic Effluent Samples
C.l Westside WWTP, Highpoint, North Carolina
Two toxic, composite effluent samples (ET50 = 21 hr and
LC50 < 10%) were obtained from the Westside WWTP in
Highpoint, NC.  Both samples, dated 3/7/88 and 3/8/88, were
passed through C18 columns.  The columns were found to be
completely ineffective in terms of reducing toxicity or
retaining any toxic organics.  This was subsequently
confirmed by the absence of toxicity in the column elutions.
However, Phase I characterization tests (see Figure 2.4 for
overview) indicated a significant reduction in toxicity with
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the addition of varying concentrations of EDTA (33).  This
would imply metals toxicity and explains why toxicity was
not removed by the C18 column.  Further laboratory evidence
from Highpoint indicated a higher than normal concentration
of nickel measured during this acute event (an influent
nickel concentration of 2.4 mg/L and an effluent nickel
concentration of 0.5 mg/L).
Besides the standard Ceriodaphnia toxicity test, the
samples were tested with Microtox.  No toxicity was found
for both samples, yet the samples were definitely toxic to
the Ceriodaphnia.  John B. Razza, a sales representative
from the Microbics Corporation, was consulted to explain
these contradictory results.  He suggested the sample should
be sonicated prior to bioassay testing as a technique to
release the metal ions associated with colloidal surfaces.
Both samples were sonicated at three different frequencies
for a total of 15 minutes, and then subsequently tested for
toxicity using the Ceriodaphnia and Microtox.  Again, no
toxicity was detected by the Microtox instrument.  However,
an increase in toxicity with sonication was observed using
the Ceriodaphnia procedure as is shown in Table 4.4; this is
consistent with the idea that metals toxicity could increase
due to the presence of free rather than bound forms.
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Table 4.4
The Effects of Sonication on ET50
of Effluent Samples Collected at Highpoint
as Measured by the Ceriodaphnia
Date ET50 ET50
Samples Pre-sonication       Post-sonication
Collected
3/7/88 21.4 hr 18.8 hr
3/8/88 31.1 hr 21.4 hr
The Microtox instriiment was successful in measuring the
standard toxicant copper used in the Ceriodaphnia
laboratory. An EC50 value equivalent to 156.3 ug/L was
determined with a 95 percent confidence interval between
141.9 to 172.2 and a correlation coefficient of 0.99998.
Thus, Microtox can detect metals toxicity, but the test
organism (marine bacterium) is apparently not as sensitive
as the Ceriodaphnia.
C.2 Cross Creek WWTP, Fayetteville, North Carolina
The first composite sample (collected from 1/16/89 to
1/17/89) obtained from Fayetteville was acutely toxic to the
Ceriodaphnia (ET50 = 3 hr, LC50 = 57%).  Phase I of Toxicity
Characterization Procedures (see Figure 2.4 for outline)
were conducted the following day (1/18/89), and the
bioassays were setup on the day after (1/19/89).  The
results from this first round of testing showed almost the
complete elimination of toxicity after the sample had been
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passed through the CIS SPE Column.  None of the other Phase
I Toxicity Characterization Procedures gave as significant
of a reduction in toxicity (for detailed results consult M.
Frey (34))
The possible importance of combined chlorine toxicity
was also noted in the first sample.  This was implied by a
decrease in toxicity observed during sample storage.  The
day the composite was collected (1/17/89), a so-called "pre-
initial" toxicity test (not stipulated by Phase I Toxicity
Characterization Procedures) was conducted resulting in an
ET50 of 3 hr; this would be considered Day 0 by the Phase I
Toxicity Characterization Procedures (Figure 2.4). The next
day (Day 1) the initial toxicity test was conducted
resulting in an ET50 of 4.3 hr.  By Day 2, the actual day
for conducting Phase I toxicity tests, the baseline of the
effluent sample had increased to an ET50 value of 13 hr.
Thus, sample storage alone reduced toxicity and could imply
that a portion of toxicity was caused by the presence of
combined chlorine (because this WWTP does not nitrify, the
chlorine added is most likely reacting with ammonia
immediately).  However, this should not rule out the
possibility of volatile organic compounds; they too could
exhibit the same reduction observed due to sample storage
(for detailed results consult M. Frey (34)).
On 1/23/89, the C18 SPE Column elution procedure was
conducted. A 500 ml portion of toxic effluent was passed
through a new C18 column and subsequently eluted.  Figure
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4.12a shows the complete retention of the toxic compounds
present in the feed to the column (see BEFORE COLtJMN) .  When
the column was eluted with the MeOH/H20 mixtures, the
majority of the toxic material was released in the 80 to 85
percent fractions as indicated by Figure 4.12b.
The second sample received from Fayetteville was
composited between 1/30/89 and 1/31/89.  This sample was
also acutely toxic, having an ET50 of 3 hr and a LC50 of
71%.  Phase I Toxicity Characterization Procedures (for
detailed results consult M. Frey (34)) were conducted on the
following day (2/1/89) and the bioassays were setup on the
day after (2/2/89).  As found for the previous sample, a
significant reduction in toxicity occurred from Day 0 to Day
2 (suggesting toxicity due to combined chlorine), and the
C18 column showed complete elimination of toxicity
(suggested toxicity due to non-polar organics).  On Day 2,
2/2/89, one liter of sample was passed through a new C18
column and subsequently eluted (Figure 4.13).  Figure 4.15b
indicates that the pattern of toxicity eluted with MeOH/H20
fractions was different than found for the first
Fayetteville sample (Figure 4.12b)  That is, the majority of
the toxicity eluted into the 80 to 85 percent MeOH/H20
fractions for the first sample as compared with the 75 to 80
percent MeOH/H20 fractions for the second sample.  This
shift may be an indication that the toxic organic
composition changed between sample dates, a span of about 15
days. However, chemical specific analyses have not been
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conducted on the fractions to determine this possibility.
The third Fayetteville sample was composited between
3/20/89 and 3/21/89.  Again, acute toxicity was observed
(ET50 = 23 hr, LC50 = 63%).  Phase I Toxicity
Characterization Procedures (for detailed results consult M.
Frey (34)) were conducted on the following day (3/22/89) and
the bioassays were setup on the day after (3/23/89).  As
with the previous two Fayetteville samples, the C18 column
retained the toxic compounds completely.  Aeration at a high
pH was the only other Phase I Toxicity Characterization
Procedure that showed the complete elimination of acute
toxicity (34).  On 3/23/89, one liter of sample was passed
through a new C18 column and subsequently eluted (Figure
4.14). The toxicity elution profile (Figure 4.14b),
resembled that of the first sample (Figure 4.12b) more
closely than that of the second (Figure 4.13b).  The 75 to
90 percent MeOH/HjO fractions eluted the majority of
toxicity compounds.
A fourth Fayetteville sample was composited between
2/20/89 and 2/21/89.  This sample also gave acute toxicity
(ET50 = 20 hr, LC50 = 63%).  The Phase I Toxicity
Characterization Procedures (for detailed results consult M.
Frey (34)) were conducted.  As found before, the CIS column
was able to retain toxicity; however, time did not permit an
elution of the column with MeOH/H20 to identify toxic
fraction.
Table 4.5 is a summary of the C18 column work conducted
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Table 4.5
Sunwry of Cross Creek UUTP Composite SaMple*
FayettevUte, North Carolina
CIS SPE Colum Results
Conposfte
Sanple Sample
Nunber Collection
Date
ET50 (hr)
Day 0   Day 1    Day 2
Toxicity MeOH/water Fraction
Rcfflovcd Containing Most
(Yes/No) Toxicity (X)
1/16/89 to 1/17/89 4.3 13
Yes 80 to 85
1/30/89 to 1/31/89 2.8 20 48 Ym
75 to 80
2/20/89 to 2/21/89 20 16 13
Vet Net Dcttnitnad
3/20/89 to in^m 23 24 30
Yes 73 to 90
to
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on the four Fayetteville - Cross Creek WWTP composite
samples.  Because toxicity was eliminated after the passage
of these samples through the C18 SPE Column (see Post-Column
Effluent results in Figures 4.12a, 4.13a, 4.14a), moderately
polar to non-polar organic compounds were indicated as a
source of toxicity.  The shift in toxicity peaks from 80 to
85 percent MeOH/H20 fractions for the first sample (1/16/89
to 1/17/89) to the 75 to 80 percent MeOH/HjO fractions for
the second (1/30/89 to 1/31/89) might be an indication that
the organic composition changed bfetween sample dates, a span
of 15 days.  However, due to the unreliable nature of the
C18 SPE Column elution procedure and the fact that the
baseline toxicity for the second sample was minimal (ET50 =
48 hr), the shift in toxicity peaks may not be significant.
Chemical specific analyses were not conducted to determine a
change in organic composition occurred between sample dates.
Further sample collection and testing will be required
to determine if moderately polar to non-polar organics are a
source of the continual acute toxicity.  Because of in-
stream dilution, the Cross Creek WWTP is not in violation of
acute toxicity but rather, chronic toxicity.  Thus, the
question remains as to whether results of a TIE aimed at
finding the cause(s) of acute toxicity can be extrapolated
to chronic toxicity.  One possible follow-up would be to
identify these compounds retained by the C18 SPE Column
using GC/MS procedures as described in the EPA Phase II
Toxicity Identification Procedures (5).  The importance of
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these compounds in producing chronic toxicity could then be
assessed through literature or laboratory study.
VI. CONCLUSIONS AND RECOMMENDATIONS
A.  Conclusions
1. The comparison study conducted between the
Ceriodaphnia and Microtox as aquatic toxicity indicators
showed that the Ceriodaphnia were more sensitive to the
target compounds tested (Table 4.3).
2. The target compound results (see section IV.B) showed
that the C18 SPE Column was capable of retaining and eluting
moderately polar to non-polar organic compounds from diluent
water.  A very rough correlation was obtained between the
major percent MeOH/H20 fraction which elutes a known
compound (as indicated by toxicity) and the log Kow value of
the compound (see Table 4.5).  The C18 SPE Column was not
able to produce a sharp elution of each target compound into
one MeOH/HjO fraction and this limited the data
interpretation.
3. Passage of the composite effluent samples collected at
the Cross Creek WWTP in Fayetteville, North Carolina through
the CIS SPE Column produced a significant reduction in
toxicity (as indicted by Figures 4.12a, 4.13a and 4.14a).
Furthermore, toxicity was successfully eluted from the CIS
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column into the 75 to 90 percent MeOH/H20 fractions (as
indicated by Figures 4.12b, 4.13b and 4.14b).  Both of these
results would indicate moderately polar to non-polar organic
compounds as a source of toxicity in the effluent of the
Cross Creek WWTP.
B.  Recommendations
1. The Microtox bioassay procedure should be utilized as
a sample screening device. Typically, a sample that is
determined to be toxic by Microtox is very toxic to the
Ceriodaphnia and combined with the fact that toxicity is
determined within 20 minutes makes the Microtox bioassay
procedure a viable system in TIE studies.
2. More target compounds should be tested to define the
achievable resolution of the C18 SPE Column and to determine
if a correlation exists between the percent MeOH/H20
fraction in which the compound is recovered and the log Kow
of the compound.
3. Further sample collection, toxicity testing and TIE
work will be required at the Cross Creek WWTP to determine
if non-polar organics are a consistent source of acute
toxicity.  Because of in-stream dilution, the Cross Creek
WWTP is not in violation of acute toxicity but rather,
chronic toxicity.  Thus, the question remains as to whether
results of a TIE aimed at finding the cause(s) of acute
toxicity can be extrapolated to chronic toxicity.  One
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possible follow-up would be to identify these compounds
retained by the C18 SPE Column using GC/MS procedures as
described in the EPA Phase II Toxicity Identification
Procedures (5).  The importance of these compounds in
producing chronic toxicity could then be assessed through
literature or laboratory study.
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APPENDIX A
Washing Procedure
In the Phase I Toxicity Characterization Procedures
outlined in draft form in January of 1987, standard
laboratory practices were established to insure and to
protect the quality of the data generated from conducting a
Toxicity Reduction Evaluation. Under this quality assurance
program, the washing procedure was outlined.  "All glassware
used in toxicity testing should be washed with detergent,
and sequentially rinsed in 10% nitric acid (to remove trace
metals), hexane, acetone (to remove trace organics), and
finally high quality water." Glassware used for the first
time should be soaked for three days in 10% nitric acid to
remove any possibility of contaminated metals. (14)
The sequencing of washes as previously outlined was
restructured due to the fact that the acetone was originally
shipped in a metal container. The 10% nitric acid wash was
moved from its leading position to the end of the washing
train to assure any metals introduced by the acetone would
be removed by the acid wash. A brief outline is listed
illustrating the washing procedure which was followed during
toxicity testing.
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'. ͣ Washing Procedure:
1. Detergent wash
2. Rinse 3 tines in tap water
3. Rinse once in hexane
4. Rinse 3 times in tap water
5. Rinse once in acetone
6. Rinse 3 times in tap water
7. Rinse 3 times in distilled water
8. Rinse and/or store in 10% nitric acid for 3 days
9. Rinse 3 times in distilled water
10. Rinse 3 times in high quality water
11. Prior to use rinse again in high quality water.
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APPENDIX B
Equipment Specifications
The following is a list of the necessary materials
required to setup three SPE column processing units as
described in the C18 SPE Column Procedure.
1. Box of C18 columns and adapters
2. 30 X 50ml test tubes with PTFE rubber caps
3. 3X1 liter reservoir bottles
4. 3 TFE needle valves with 1/8" NPT thread
5. 3 PFA male connectors for 1/8"OD
6. 3 PFA male connectors for 1/4"OD
7. 3 X 1-liter vacuum flasks
8. 6 customized rubber stoppers
9. 12 FT of 1/8"OD TFE tubing
10. 12 FT of 1/4"0D TFE tubing
11. Disposable syringes 5ml & 10ml (boxes)
12. 10 X 125ml polypropylene wide mouth bottles
13. HPLC grade methanol (1 liter)
14. House vacuum or suitable pump
15. 3 magnetic stirrers with stir bars
16. 26 FT of vacuum hose and vacuum piping
17. 2 X 100ml graduated cylinders
18. 1 utility box (4X5X8 inches)
19. 6 FT of Piano wire
20. 48 X 5ml vials with PTFE rubber caps
21. 2 microliter syringes
22. 10 plastic centrifuge tubes
23. 4 FT glass tubing 7/32 OD
105
APPENDIX C
Request and Reporting Forms
'(
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LOG #:_____
BI0A86AY REQUEST FORM
Ceriodapnia dubia
NAME:_____________________________ DATE:.
SAMPLE I.D.:______________________     LOCATION:
SAMPLE DATE:__________  TREATMENT DATE    _______ TIME:__
TYPE OF TEST:  __  TIMED LETHALITY (10 mL; no dilutions)
__ TIMED LETHALITY (10 mL; w/ dilutions)
__ ACUTE STATIC (100 mL; 24 & 48 HR LC50)
__ 7-DAY MINI CHRONIC (15 mL; reproductive)
OTHER (_______________________________)
SPECIAL INSTRUCTIONS:
RESULTS:  _A ET50=
B  LC50=
_C  CHRONICA   PASS / FAIL
REQUEST RECEIVED BY:______________
DATE:________________
TEST DATES:__________________ to
COMMENTS:
SAMPLE I.D.:__________
CONTROL/DILUTION WATER
INITIAL:
Filter:_____ Temp:___
TIMED LETHALITY TEST DATA / WORKSHEET
Ceriodaphnla dubia
SOURCE:____
pH;_____ D.0.!_
NAME:
LOT #:
Alk:
INITIAL DATE:
FINISH   DATE:]
TEST VOL:
TIME:
TIME:'
Hardness:
ANALYST:
ANALYST:'
Cond:
COMMENTS:
« ORGANISMS/CUP DILUTIONS:
ADULTS
ISOLATED AT:
SAMPLE
REPLICATE
# ORGANISMS
A !  B
TIME:  NAME
Tcmo (C)
vH
DO   rma/L)
H
O
-J
108
APPENDIX D
Microtox Test Procedure
The following procedure was developed as a quick
reference guide for verifying the readiness and assisting in
the operation of the Microtox Unit.  This procedure combines
the structural format of the Abbreviated Assay Procedure for
Duplicate Determinations (35) and the additional
instructions outlined in the Microtox Manual:  How to Run a
Standard Microtox Test (17).  The purpose of including this
guide is to illustrate the experimental procedure which was
followed and to assist anyone that may use the instrument in
the future.
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Analyzer Readiness Guide
1.  INSTRUMENT INSPECTION
* Insure that the Microtox unit is plugged into a powered
outlet and has been operating for at least 15 minutes
before attempting this procedure.  Ideally the
instrument should be left operating on a continual
basis during periods of frequent testing.
* Visually inspect the instrument and surrounding area for
possible obstructions which may block the wells or
ventilation ports.
2. VERIFYING TEMPERATURE SETTINGS
* Precooling well should be at 5 degrees C
* Turret and incubating wells should be maintained at
15 degrees C but may vary between 12 C to 25 C.
* If the temperature of the turret or incubating wells is
unsatisfactory it may be adjusted using the Temp Set
control.  <Unlock> the Temp Set control and Twiddle the
dial until it reads 1.5 or the LED display indicates a
temperature in the proper range, then <lock>.
3. INSTRUMENT CALIBRATION
* Select the X-10 Sensitivity Range by depressing the X-10
button.
* <Unlock> the Span control and then turn it clockwise to
its maximum setting. <lock>
* Depress the HV or High Voltage Switch to the On
position.  The photomultiplier is now energized and
should be allowed to stabilize before continuing.
* With the turret closed and no reagent, the LED display
should read 0 0 0.  If this is not the case the
instrument will need to be zeroed.  To zero the
photomultiplier output <unlock> the Zero control and
twiddle the dial until 0 0 0 reading is obtained then
<lock> the control.  This adjustment should only be done
with X-10 Sensitivity range and the Span control turned
to its maximum setting.
110
4.  CALIBRATION CHECK
* <Unlock> the Span control and turn it counterclockwise
to a setting of two, and then very carefully turn the
control clockwise until the large outside ring is set to
four and the inside dial is set to zero <lock>.
* Verify that the turret is closed. Span control is at 4.0
and Sensitivity range is set in the X-10 mode.
* Depress the CAL Check button and look at the LED
display.  The display should indicate a value between 80
to 120.  If this value is not obtained consult the
Microtox Manual page 12.  Release the CAL Check button.
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Microtox Assay Procedure
1. ANALYZER PREPARATION
* Verify analyzer readiness (previous procedure)
* Remove storage cuvettes from wells and replace them
with new clean cuvettes.
* Add 1.0 mis of Reconstitution Solution to cuvette in
the preceding well.
* Add 1.0 mis of Microtox Diluent to wells Al through A4
* Add 0.5 mis of Microtox Diluent to wells CI through C5
2. SAMPLE PREPARATION
* Visually inspect the sample to determine if the light
absorbance correction procedure will be necessary
* Place 2.5 mis of sample into well A5
* Adjust NaCl concentration of the sample by adding 0.25
mis of Microtox Osmotic Adjustment Solution to well
A5.  Mix this well five times with pipettor.
* Transfer 1 ml from well A5 to A4 and mix five times
with pipettor.
* Transfer 1 ml from well A4 to A3 and mix five times
with pipettor.
* Transfer 1 ml from well A3 to A2 and mix five times
with pipettor
* Wait five minutes for temperature equilibrium.
3. REAGENT PREPARATION (Read Before Attempting)
* Opening the reagent bottle
- Note hissing sound due to vacuum packing.
Disregard reagent if no sound is heard.
- Seat the reagent pellet into the bottom of the vial.
* Reconstituting reagent
- Take the cuvette of Reconstitution Solution from the
precooling well and place the reagent bottle right
under the lip of the cuvette.
- "Suddenly" dump the Reconstitution Solution into the
bottle
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- Swirl the bottle three to four times fast.
- Pour the contents back into the cuvette and place
the cuvette back into the precooling well.
- Aspirate twenty times with the 250 ul pipettor and
start recorder chart drive.
* Transfer 10 ul of reconstituted reagent to wells CI
through C5.
* Flick each cuvette five times with finger.
* Depress XI Sensitivity range.
* Place the cuvette from well CI into the turret and
close.
* Adjust the DPM reading to approximately 0 9 0 by using
the Span control.  <unlock> adjust <lock>
* Verify reagent equilibrium by watching the chart
recorder.  (Approximately a 15 minute wait)
4.  ASSAY PROCEDURE
* Take initial reagent readings cycling the cuvettes in
the following order:
CI, C2, C3, C4, C5
Reset Span if any of the cuvettes read over 100 and
cycle cuvettes again.
* Immediately transfer 500 ul from well Al to CI and mix
by aspirating and dispensing 5 times with the pipettor
* Using the procedure previously described, make the
following dilution transfers
500 ul From A2 to C2
500 ul From A3 to C3
500 ul From A4 to C4
500 ul From A5 to C5
Aspirate and dispense 5 times after each transfer
* Five minutes after the last I (0) light level was
taken as indicated by the chart recorder, cycle the
cuvettes in the following order to obtain the I (5)
light levels:
CI, C2, C3, C4, C5
* If the test indicates a stepwise regression then
toxicity exists, and the results can be tabulated and
reduced.
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Fifteen minutes after the last I (0) light level was
taken, recycle the cuvettes in the following order to
obtain I (15) light levels:
CI, C2, C3, C4, C5
If the test indicates a stepwise regression then
toxicity exists, and the results can be tabulated and
reduced.
It is possible to repeat the cycling of the cuvettes
for light level readings up to 30 minutes or more
beyond the last I (0) reading if deemed necessary.
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APPENDIX E
Log Octanol/Water Partitioning Coefficient
Estimations
for
Target Compounds
Phenol (Ph)
Chemical Formula: C^HgO
Chemical Structure:
Calculation:
Leo^s Fragment Constant Method (27)
f« „ =   1(1.90) =   1.90
+ fgjj =    l(-0.44) =  -0.44
log Kq^  =   1.46
(Observed log Kq^ «=  1.46)
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1 - Methylnaphthalene (MN)
Chemical Formula: C20H7CH3
Chemical Structure:
CH,
o Q
Calculation;
Leo's Fracrment Constant Method   (21)
^^Sh = 7(0.355) = 2.48
.fSo = 1(0.255) = 0.26
+ f °* = 1(0.44) = 0.44
-   1(0.23) = -   0.23
^CH3 0.89
= 0.89
log Ko„  =  3.84
(Observed log K^^  = 3.9)
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Nonyl phenol ethoxylate 9 Mole  (NPE)
Chemical Formula: CjjHgQOj^Q
Chemical Structure:
^C:>s^O(CH2CH20)9H
R-CH-CH,-CH-CH,-CH-CH,I I i ^
Cn^    CH"i    CHo
Calculations:
Leo^s Fragment Constant Method f27^
*C6"5  ° 1(1.90) = 1.90
+  9£
CH3
9(0.89) = 8.01
-"h- - 9(0.23) - - 2.07
*  8£o- 9(-1.82) - -   14.56
*  'OH- 1(-1.64) sc -   1.64
*'§- 1(-0.61) - -  0.61
-'S- l(-0.23) - -  0.23
.f°. 1(0.20) - 0.20
+ 3f„ - 3(0.23) - 0.69
+  2fc- 2(0.20) - 0.40
* "CH3 - 6(0.89) = 5.34
-"h = -  2(0.23) - -  0.46
\-
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Nonyl phenol ethoxylate 9 Mole  (NPE) continued
+ (37-l)Fj3 = 36(-0.12)  =  - 4.32
log Ko„  =  - 7.35
(Observed log Kow not available)
Mailhot and Peters* Empirical Relationship Method (28)
Nonyl phenol ethoxylate (NPE):
Molecular Weight = 616.4 gm/mol
Density = 1.057 gm/cvcr
This method is based on the relationship between log Kow and
different physiochemlcal propeirties for the alkane family.
Molecular Weight (M):
/ Linear Equation:  log K^^ = 1.12 + 0.024M
(n = 17, r^ = 0.728, MSE = 0.156)
Calculation:  log Kq^ = 1.12 + 0.024(616.4 gm/mol)
log Ko„ = 15.9
(no observed value)
Density (D):
Linear Equation:  log K^^ = -4.26 + 11.4D
(n « 17, r^ «= 0.701, MSE = 0.172)
Calculation:  log K^^ = -4.26 + 11.4(1.057 gm/cw?)
log Kq^ =7.8
(no observed value)
Di - n - octyl phthalate (DOP)
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Chemical Formula: C24H3QO4
Chemical Structure:
C-O-CgHi^
C-O-CgHi^
Calculation:
Leo^s Fragment Constant Method f27^
^CfiHs — 1(1.90) — 1.90
- f° = - 1(0.23) « - 0.23
+ f°
CO2
= 2(-0.56) = -1.12
+ 2(8)fcH3 = 2[8(0.89)] - 14.24
+ 2(7)fjj = 2[-7(0.23)] = - 3.22
+ (18-l)Fb ^ 17(-0.12)
log Ko„
^ -2.04
9.53
(Observed log K^^ »= 9.2)
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APPENDIX F
Time Based Toxicity Unit Data Tables
TABLE 0.1
PERCENT METHANOL EVALUATION
FOR FICWRES 4.1(A) AND 4.1(B)
BOTTLE NO. 1 (4 LITER)
LOT NO. 873940
OPENED 3/15/88
=rcsasac«ra«««*a aHnEBssssssBsssssssszrsrassssssKxsssssxzssssBrsssBnnarimrsKCBaBsa
SAMPLES
TIME BASED TOXICITY UNIT (TTU)
essssessssssssxBSSSSss££sssss!ssss=ssssssssssss==««BSS===ssrssssss=s=ssssssss=sss=a
BIOASSAT CONDUCTED IN PLASTIC CUPS 11   GLASS BEAKERS
3/16 4/27 I 4/27 I 4/27 | 7/22 | 7/22 | 7/22 7/19/88
4.8
11.5
=sssss5ass==
1    0.0 0.0 0.0 0.0 0.0     1
1    0.0 0.0 0.0 0.4 0.0      1
1    0.0 0.0 0.0 0.0
0.0
0.0
0.0
0.4
2.2 1
2.6      1
4.3 1
1.3      1
0.9      1
1    0.0 0.0 10.0 7.0 0.9      1
1    3-9 6.0 8.0
1  10.3 9.1 13.1
0.0
0.0
0.0
0.4
0.8
0.8
0.9
2.2
1.6
2.1
4.9
1.2
13.7
18.9
:asss=sE9esss9ssssssEssss=z>sssss>ssssssns=rssssssss=rssssss8sssssssssssss==
to
o
TABLE 0.2
COLUMM TOXICITY EVALUATION
FOR FIGURES 4.2(A) AND 4.2(8)
BOTTLE MO. 1  (4 LITER)
LOT MO. 873940
OPEMED 3/15/88
==as===s=ess=ssa=a«»«Bsass==s==ai=a==ssa========rassss=as======
II II SAMPLES II
II          II     TIME BASED TOXICITY UNIT (TTU)      ||
I 1  PERCENT   1 |sssssss=sssss===s=£==sss=s===:=ssss======;=====
II METHANOL  j j      PLASTIC CUPS     || GLASS BEAKERS ||
II         II 3/22  1 7/20 1 8/4 || 7/19 | 8/5  ||
s=s=sss!sas=r=====s=er=as=»=2:rs===s=ssssess=sfi=s=asr=:sr==r=r=es
II 0.38 II 1 1 0.0 II 1 0.0 II
II 0.50 I I 0.0 I 0.0 1 II 0.0 I II
II 0.75 II 1 I 0.0 II 1 0.4 II
II 1.00 I 1 0.0 1 0.0 I II 0.0 1 II
II 1-13 II 1 1 0.0 II 1 0.0 II
II 1-20 II I I 0.0 II I 0.0 II
II 1-28 II 1 I 0.0 II 1 0.4 II
II 1-35 II 1 1 0.4 II 1 7.8 II
II 1.43 I I 1 1 0.4 II I 14.8 II
II 1.50 1 1 0.0 1 0.0 1 0.4 II 1.1 I 14.3 ||
II 1-60 1 1 0.0 1 0.0 1 II 0.7 1 II
II 1.70 I 1 0.0 1 0.0 I II 0.7 1 II
II 1-80 1 1 0.0 1 0.4 1 II 10.3 1 II
II 1-90 1 1 5.3 1 7.9 1 II 10.8 | ||
II 2.00 I 1 0.0 I 7.5 1 II 13.3 j ||
II         1 1      1      1     II     1      II
B=sssssassesssssses=srsssss=
to
TABLE 0.3
COIUMM TOXICITY EVALUATION
FOR FIGURE 4.2(C)
BOTTLE MO. 2 (1 LITER)
LOT NO. 884151
OPENED 8/16/88
PERCENT
METHANOL
0.38
0,75
1,13
1.20
1.28
1.35
4.43
1.50
SAMPLES
TIME BASED TOXICITY UNIT (TTU)
BIOASSAY CONDUCTED IN PLASTIC CUPS II
9/22  I 9/23 9/27 9/28
ssssss:s==Ksssssssx=sss:
0.8 I 0.0 I 0.0 I 0.0
0.0 I 0.0 I 0,0 I 0.0
0.4 I 0.0 I 0,0 I 0,0
0.4 I 0.0 I 0,0 I 0.0
0.0 I 0.0 I 0,0 I 0,4
0,0 I 0.0 I 0,0 I 0.0
6.1 I 4.3 I 5.7 I 3.5
13,5 I 3,4 I 2,4 I 1.8
sss==ssf:ss=s==
II
II
II
H
to
to
TABLE D.4 TABLE D.5
TIME LETHALITY TOXICITT UMIT DATA
FOR FIGURE «.3(A)
TIME LETHALITY TOXICITT UMIT DATA
FOR FIGURE A.3(B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 8/10/88
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 8/10/88
NON-TOXIC EFFLUENT FROM HIGHPOINJ NC
1,5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
NON-TOXIC EFFLUENT FROM HIGNPOINT NC
1.51C METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
&sssssssses«ns«s&xxssssssssssssssss=ssssssx9ssrcsrs
1   VOLUME OF SAMPLE   | 1 TIME BASED TOXICITY |
1    PASSED THROUGH    | 1     UNIT (TTU)      1
1   C-18 CaUMN (mts)  1
ssssssssssrss=sseessESssas=3ssssrsasssssssssssssssssBS
1   BEFORE COLUMN      | 1               oc               1
1       1C0          1 1      0.0      1
1       500          1 1       0.0       1
1       750         1 1       0-0       1
1       850         1 1       7.3  .    1
1       950         1 1       0.0                  1
S53scxs£===asss3»ms««c=:ss="sszsswissssssasscssxsasas
ess&sssesss Esssssssssssssssssssasaa
SPE C-18 COLUMN EXTRACTION
PERCENT METHANOL / WATER
ELUTION
25
50
75
80
85
90
95
loo
sssssssssscsszssscess&s
TIME BASED TOXICITY
UNIT (TTU)
PLASTIC GLAS$
ssEsa=asaiBSB3:ra=a=a==a=;
O.D 0.0
0,0 0.8
0.0 2.0
0.0 1.2
0.0 0.0
0.0 5.7
0.8 7.7
0.9 6.9
BSBassacss£sssssss8cssBsssamSBezs9ss:sa=z:
H
TABLE D.6 TABLE 0.7
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.4(A)
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.4(B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 10/5/88
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 10/5/88
CONTROL WATER FROM BOTANY POND
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
CONTROL WATER FROM BOTANY POND
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
sssscs3BXECSssss«asxKascHS«ssKBSxsr excess
VOLUME OF SAMPLE
PASSED THROUGH
C-18 COLUMN (mis)
BEFORE COLUMN
100
500
750
850
950
TIME BASED TOXICITY
UNIT (TTU)
sssssssssssssszssssssss
0.0
0.0
0.4
0.0
0.0
0.4
zsssmassssssEssa
cssss£SSS=5s:s====sEX:=siSSIiSSSS5=BS=SSSSSSSS3==SS=&SSSS=SSSXSasaSS
1   SPE C-18 COLUMN EXTRACTION | 1    TIME BASED TOXICITY  |
1    PERCENT METHANOL / WATER  1 1       UNIT (TTU)      1
1          ELUTION
1            25 1                    o-^                1
1            50 1          0.0        1
1            75 1          0.4        1
1           80 1         0.0       1
1            85 1          0.4        1
1            90 1         0.0       1
1            95 1          3.3        1
1           100 1          2.2        1
TABLE D.8 TABLE 0.9
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.5(A)
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.5(B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 9/22/88
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 9/22/88
PHENOL
(10 X LC50 * 4.3 wg/L)
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
PHENOL
(10 X LC50 = «.3 mg/L)
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
=ssss9Srs=s=sssssssssssssesssessssss=3Ssss ss=a>a>ssssss
VOLUME OF SAMPLE
PASSED THROUGH
C-18 COLUMN (mis)
ssassssKSSEsssssssccsasssssssssssssssssssess
BEFORE COLUMN
100
500
750
850
950
TIME BASED TOXICITY
UNIT (TTU)
6.5
9.0
7.4
10.2
9.5
9.2
1   SPE C-18 COLUMN EXTRACTION | 1    TIME BASED TOXICITY  |
1    PERCENT METHANOL / WATER  | 1       UNIT (TTU)      1
1         ELUTtON          1 1
1            2^            1 1          0.0 (-0.4) 1
1            50            1 1          0.0
1            75           1 1          0.0 (-0.4) 1
1           80           1 1          0.0
1            85           1 1          0.0 (-0.4) 1
1           90           1 1          0.0
1           95   •       1 1          0.1
1          100          1 1          0.0 (-0.1) 1
to
TABLE 0.10
TIHE LETHALITY TOXICITY UNIT DATA
FOR FIGURES 4.6(A) AND 4.6(B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED OH 9/22/88
PHENOL
(10 X LC50 « 4.3 mg/L)
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
1   VOLUME OF SAMPLE   | | TIME BASED TOXICITY
1    PASSED THROUGH    | |     UNIT (TTU)
1   C-18 COLUMN (mis)  || pH=3 pH=7 pH«9
s«sasssars!s=sra=r=====a«»««=
ABSORBANCE DATA     |
(ABS)         1
pH = 3 pH = 7 pH=9 1
1                  1 1
1   BEFORE COLUMN      j j  10.7
1                    II
10.7 10.7 0.66  0.66 0.66  1
1                   1 1
1       25         II  11.1
1                  II
7.0 7.6 0.322 0.672 0.644  1
1                  1 1
1       150         II   6.9
1                 II
5.9 10.0 0.628 0.667 0.653  1
sssssamsmnasrssrsssssssssasseSMSsssssssssssssssssasssssssssssrsssass
to
TABLE 0.11
TIME LETHALITY TOXICITY UNIT DATM
FOR FIGURE «.7(A)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 8/5/88,7/13/88,7/6/88
1-METHYLNAPHTHALENE
LC50 » 1.393 ul/L
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN GLASS BEAKERS
esssss===s£ssssss=s=s=srssssssesssssssscsssssss£ss=s
1   VOLUME OF SAMPLE   | |           TIME BASED
£S=SaS=S=SSSSS3
TOXICITY UNIT (TTU)         1
1   C-18 COLUMN <mls)  1 1    2.8 ul/L    | 7,0 Ul/L   1 3A.8 ut/L   1
1                   1 1    2 X LC50    1 5 X LC50   1 25 X LC50   1
Is£s=sss==£ss=sssss=ssssscsasssssss=sssss5ess=ssssss ==ssr===rras=s!£sas=ss£ss=s:ss=s=s
1   BEFORE COLUMN      | |        0.8     | 10.4    1 100.0    1
1       100         II        2.9    1 1.6    1 1.2    1
1       500         II        0.4    1 0.4    1 2.7    1
1       750         II       0.0    1 0.0    1 A.O    1
1      850         II       0.0    1 0.0    1 0.8    1
1       950         II       0.0    1 0.0    1 3.9    1
to
TABLE D.12
TIME LETHALITY TOXICITY OHIT DATA
FOR FIGURE 4.7(B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 8/5/88,7/13/88,8/9/88
1-HETHTLNAPHTHALENE
LC50 « 1.393 ul/L
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED  IN PLASTIC CUPS
ssssscs=ssaes=ss3csssszs=sssssKsscMsssaicr«ns9se«sscsssttesssssBssesrc9>Bn«tt9arssscc>a:«ssEcs«ssesssssssssssssesscscseecs«ssssssscssscssssrsea
I ISPE C-18 COLUMN EXTRACTION
PERCENT METHANOL / WATER
ELUTION
rsMWerssssssss«BSsxc«cascessexscss:
TIME BASED TOXICITY UNIT (TTU)
25
50
75
80
85
90
95
100
2.8 ul/L
2 X LC50
:scEss«Esn«»B>sBxsKan«KBsa»sassse«KnsccsassKczssssssssrsseesssss==ssssss=ssssss=ESSsr'
0.0
0.0
0.0
0.0
0.0
0.0
4.2
2.3
7.0 Ul/L
5 X LC50
0.0
0.0
0.0
0.8
0.0
0.0
5.8
5.3
34.8 ul/L
25 X LC50
0.4
0.0
3.5
61,8
0.0
0.0
5.2
3.4
ssbsssbsbsbbsb:
H
to
03
TABLE 0.13
TIME LETHALITY TOXICITY UMIT DATA
FOR FIGURE 4.7(C)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 8/5/88,7/13/88,7/6/88
1-METHTLMAPHTHALENE
LC50 = 1.393 ul/L
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN GLASS BEAKERS
==£SSS=S=S==SSSSS=£9:S=XS=SSSSSISSSSSSI
SPE c-18 COLUMN EXTRACTION
PERCENT METHANOL / WATER
ELUTION
ssBessssssseecaesEassssesss*eBssaEBsssesssssstis9sssszsEssasssassBs=sssesssssBaassas
TIME BASED TOXICITY UNIT (TTU)
25
50
75
80
85
90
95
100
2.8 ul/L 7.0 u l/L           1        34.8 ulA           1
2 X LC50 5 X LC50            1        25 X LC50           |
0.0 0.0 1         0.0
0,0  (-0.8) 0.0 (•0.8)       1         0.0 (-0.8)       1
0.3 10.3 1         15.7
1.5 26.6 1        98.8
0.0 0.0 1         8.7
1.8 1.0 1         7.4
5.6 1.6 1         4.8
6.4 0.0 (-2.0)       1         5.2
SBseaaaaassBBBaaaaaaBBaaaassssaBaeas
H
TABLE D.14
TIME LETHALITY AND MICROTOX DATA
FOR FIGURES 4.8(A), 4.8(B) AND 4.8(C)
FRACTIONATION SPE C-18 COLUMN
1-MCTHYNAPHTHALENE
(5 X LC50=1.393ul/l)
1.5X METHANOL EXTRACTION
Bssss«s«cr=====s=======
SPE C-18 COLUMN EXTRACTION
PERCENT METHANOL / WATER
ELUTION
25
50
75
80
85
90
95
100
MICROTOX TOXICITY UNIT
(1 / EC50) X 100X
s=ssrsses3sssss=ssssrss=i
0.0
0.0
1.7
3.7
0.6
0.0
0.0
0.0
CERIOOAPHNIA OUBIA TOXICITY
(1 / ET50) X 100X
PLASTIC GLASS
0.0
0.0
0.0
0.0
0.0
0.0
6.0
5.0
:ss:!=ssssssass:
0.0
0.0
6.8
17.8
0.0
3.7
3.9
0.0
o
TABLE D.15
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.9(A)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 9/26/88,9/27/88,9/29/88
NONYL PHENOL ETHOXYLATE
LC50 » 5.5 mg/l
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
S:SSSSS==SS=SS£==SSSSSSS=SSSSSSSSSSSSS=SSSSSSSSSSS5SS
1   VOLUME OF SAMPLE   | |           TIME BASED
srsssssssasrss:
TOXICITY UNIT
SS=S=S=SSStfS==SSSS
CTTU)        1
1   C-18 COLUMN (fflls)  1 1    11 mg/L    | 27.5 mg/L  | 55 mg/L   |
1                  1 1    2 X LC50    1 5 X LC50   1 10 X LC50   1
1   BEFORE COLUMN     | |       15.6    j 10.9    1 19.6    1
1       100         II       0.0    1 0.4     1 0.0    1
1       500         II        0.(,            1 0.0    1 0.0    1
1       750         1 1        0.0    1 0.0    1 0.0    1
1       850         II        0.0    1 0.0    1 0.0    1
1      950         II       0.0    1 0.0    1 0.0    1
asaasEsssnssss:
TABLE 0.16
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.9(B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 9/26/88,9/27/88,9/29/88
MOMYL PHENOL ETHOXYLATE
LC50 ' 5.5 mg/l
1.SX METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
ssxsszssssEZBZsazsssKsszzzsssEZBSsssaxaEaxesBsKSCKSsesBsssssaEXZScssasssneeczESBseussKKacszEZXZBssssscssseEBSZssssssxssssEsssssrssxsssssxsszzs
1   SPE C-18 COLUMN EXTRACTION | j TINE BASED TOXICITY UNIT (TTU)                                |
1                     ELUTION                       I   1                      11 mg/l                           (                       27.5 mg/l                         j                     55 mg/l                            (
1                        II         2 X LC50          1         5 X LC50           |        10 X LC50           |
1            25            II          0.0 (-0.4)        1           0.0 (-0.4)       1         0.0  (-0.4)       1
1            50            1 1          2.1 1           0.0 1                 o-t)                         1
1           75           1 1         0.0 (-0.4)        1           5.7 1         12-7             1
1           80           II         U.2 1          18.0 1        35.7             1
1           85           II         17.6 1         18.3 1        26.7             1
1           90           II         3.6 1          6.0 1         9-9             1
1           95           1 1         1.6 1          0.0 (-1.1)       1         0.5              1
1          100           II         6-5 1          0.0 (-0.1)       1         0.4              1
==ss«ccK«ec«asssssBB«a BSSBSSESESE ESSSZBSSSSSSSZEZESSSBaBSSSSBBSZSZSSeSSBBBBSSeBSS SSSBSCBBSa
H
CO
w
TABLE 0.17
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURES 4.10(A) AND 4.11(A)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 10/11/88,10/6/88,10/7/88
DI-N-OCTYL PHTHALATE
LC50 = 89.7 mg/l
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
S;=ssss=s=ss==ssss==srsssss9ss*=s!£s=*'sssr5sssss=ss£s=ssss:sss=ssrss==sssr==r=s=s=s====
1   VOLUME OF SAMPLE   | |            TIME BASED TOXICITY UNIT (TTU)          |
1 c-18 COLUMN (mis) 1 1 164 mg/L | 491 mg/L j 1473 mg/L |
1                   1 1    1.8XLC50   1   5.5 X LC50  j  16.4 X LC50  |
|sss=s=s===s===sszs=sssssssssssaEssss==ssssr=CKssssrssss===s=ssssssrs====s=====s==rs==
1 BEFORE COLUMN | | 4.2 | 5.1 | 16.0 |
I 100 II 7.8 1 0.0 1 0.0 1
1 500 I 1 8.8 I 0.0 I 3.0 11 750 II 8.8 1 0.8 I 10.2 j1 850 II 8-8 1 1-2 1 10.7 j1 950 II 8.8 1 3.6 I 13.4 j
1                  II              1             1             1
:sssss=sssas ES====SSCS
TABLE 0.18
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.10(B) AMD 4.12(A)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED OH 10/11/88,10/6/88,10/7/88
DI-N-OCTYL PHTHALATE
LC50 = 89.7 mg/l
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED  IN PLASTIC CUPS
e======s:===============Ms=«xB«a=s=E8==s«asE=sssre==r s3esassssxB«ssaesssscsessss£sssssrxsssa£ss;=====%SBSS===xss=s=-rsssBsssss=s=-=ssssss=s==—s===
1   SPE C-18 COLUMN EXTRACTION  | | TIME BASED TOXICITY UNIT (TTU)                                  |
1     DrOrCUT MFTUAUm / UATrD   ....._•.••.••..........
1         ELUTION         1 1         164 mg/L          |         491 mg/l           |        1473 mg/L           (
1                        II        1-8 X LC50          I         5.5 X LC50           |       16.4 X LC50          |
1           25           II         0.0 (-0.4)        1           1.6               1          0.0  (-0.4)       1
1           50           II         0.0 1           1-1               1          4.2        .      1
1           75           1 1         4.3 1          6.6              1        20.2             1
1           80           II         8.1 1          2.3              1        11.1              1
1           85           II         7.5 1          5.6              1        13.7             1
1           90           1 1         19.3 1          9.0              1        20.9             1
1           95           II         23.7 1         22.5              1        24.6              1
1          100           1 1         6.1 1          7.8           •  1        13.1              1
sssHsnmascrss==sessscsssamKsssss=assaB«sssrssssr=sxeean>ssaBS»«nEssss*n>BsacEC£csssaBB«nssssssBBsss=s
TABLE D.19
TIME LETHALITY TOXICITY UHIT DATA
FOR FIGURE 4.11 (B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 10/11/88,10/6/88,10/7/88
OI-N-OCTYL PHTHALATE
LCSO = 89.7 mg/l
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
ecsssssssssssssssssesssars sssssasssssasssarss =sssxsE=BSEse»==rssaa=sssssssssssscssss
1         VOLUME OF SAMPLE         |
1           PASSED THROUGH           |
1        C-18 caUMN (m(s)      1
(1 / ET50) X 100X 1
1            164 mg/L 1         491 mg/L        | 1473 mg/L        |
1                                                1 1          1.8 X LCSO 1       5.5 X LCSO      1 16.4 X LCSO      1
1         BEFORE COLUMN               | 1                   2.6 1               3-^           1 11.1            1
1                100                     1 1                   5.7 1             0.0          1 0.0            1
1                  500                        1 1                   6.1 1               0-0           1 2.7            1
1                  750                        1 1                   6.1 1               0-0           1 8.3           1
1                  8^0                        1 1                   6,1 1             0.0          1 6.9           1
1                  950                        1
1                                                1
1                   6.1 1               2-6           1 10.0          1
H
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TABLE D.20
ABSORBANCE DATA COLLECTCO ON 10/13/88,10/8/88,10/9/88
FOR FIGURE 4.11(C)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 10/11/88,10/6/88,10/7/88
OI-N-OCTTL PHTHALATE
IC50 = 89.7 mg/l
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
ABSORBANCE READ AT THE END OF THE BIOASSAY TEST
S=SSSS=SSSS9SSXSSSSSSSESSSS=SS!SSSS==S9SSSS=SSSSSSSSS=SSSSSS====S=SSSSSS===rS=SSSS==£a
1 VOLUME OF SAMPLE | | ABSORBANCE (A6S> |
1     DACccn TUDrmru     1 1........................................................
1 C-18 COLUMN (mis) | j 164 mg/L | 491 mg/L | 1473 mg/L |
1                   I 1    1.8 X LC50   1   5.5 X LC50  |  16.4 X LC50  |
1 BEFORE COLUMN j | 0.080 j 0.287 ] 0.209 jI 100 II 0.330 1 0.044 j 0.004 |1 500 1 1 0.550 1 0.060 j 0.011 |1 750 II 0.560 1 0.060 j 0.055 jI 850 II 0-560 I 0.064 j 0.089 jI      950         II      0.570    1    0.072    |    0.194    j
M
TABLE 0.21
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.12(B}
FRACTIONATION SPE C-18 COLtMN
BIOASSAY STARTED ON  10/11/1)8,10/6/88.10/7/88
OI-H-OCTYL PHTHALATE
LC50 « 89.7 mg/l
1.5X NETHANa EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
SPE C-18 COLUMN EXTRACTION
PERCENT METHANOL / WATER
ELUTION
's==s9scssn«a*ssnzxsssssecesBBsesssBKB>ezBssssssscssKSSBsssrssssssssssssrs=sxssssssrssEssssssrsssssssssssss
<1 / ET50) X 100X
SSSBSSSZSSSSSS BBSBSSSSBBBSSesSS
25
50
75
80
85
90
95
100
1  1                     1M mg/L «91 mg/l 1                    1473 mg/L
II                   1.8 X LC50 5.5 X LC50 16.4 X LC50
===SBSBSBXXBBB===BaBS=BBE===ESBaSBBB= =BBBSBBSsss=r-s*====sss=3ss=:ss=ssasss;: ====S=S=5S==S
1   1                      0.00 0.00 0.00
1   1                       0.00 0.00 3.07
II                       2.7« «.78 17.54
1   1                       5.46 2.08 8.33
1  1                      5,59 4.17 10.20
1  1                    11.63 6.21 17.54
1  1                    30.30 25.00 32.26
1  1                      5.88
II
6.85 10.75
1  1
BBssaaBaasBBs==sssssBssnesBK«raBBttB93 —«»Bnn.« - - -
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TABLE D.22
ABSORBANCE DATA COLLECTED ON 10/13/88,10/8/88,10/9/88
FOR FIGURE A.12(C)
FRACTIONATION SPE C-18 COLUNN
BIOASSAY STARTED OM 10/11/88,10/6/88,10/7/88
OI-M-OCTYL PHTHALATE
LC50 = 89.7 mg/l
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
ABSORBANCE READ AT THE END OF THE BIOASSAY TEST
ss)i»K«ssssssssessss&sssscsssEsssssssezsssEessssscsssss«ssssesasssscx«9ssssssssssx9ttecBSfi£ssssssss=ssssssssss<ssaessBsssEsssesssssasrsssssrsssasssss
1         SPE c-18 COLUMN EXTRACTION     |   | ABSORBANCE (ABS) 1
1                     ELUTION                       1  1                      164 mg/L                         |                       491 mg/t 1473 mg/L                          |
1                                                  II                 1-8 X LC50                         1                        5.5 X LC50 16.4 X LC50                         1
srSSSSSSSSSKSSSSSSSSSSSEeSSSSSSSSSSSSesSESSSSSflCXSSSSSS sssasscssssssacasssssexftssssssssssssssssssssssssssrssss::==ssssessss=sss==ssxssssssrsss=s==a=
1                            25                            II                    0.004 1                        0.004 0.003                                  1
1                            50                            II                     0.006 1                      0.001 0.010                                 1
1                              75                              II                      0.034 1                      0.022 0.080                                  1
1                            80                            1   1                     0.053 1                      0.028 0.075                                    1
1                            85                            II                     0.110 1                      0.054 0.300                                    1
1                              90                              II                      0.289 1                      0.200 0.667                                    1
1                            95                            II                     0.522 1                      0.603 1.199                                    1
1                            100                              II                      0.285 1                        0.238                                     1                     0.346                                    |
03
TABLE D.23
TIME LETHALITY ANO MICROTOX DATA
FOR FIGURES 4.13(A) AND 4.13(B)
FRACTIOMATIOM SPE C-18 COLUMN
DI-N-OCTYL PHTHALATE
(X)NCENTRATION = 1473 mg/L
1.5X METHANOL EXTRACTION
SPE C-18 COLUMN EXTRACTION
PERCENT METHANOL / WATER
ELUTION
sssassBsrssss===ssssssssrsss
25
50
75
80
85
90
95
100
MICROTOX TOXICITY UNIT
(1 / EC50) X 100X
essssssss
0.0
1.4
10.2
3.8
35.7
0.4
0.6
1.3
ssasnsassccssss: =SSS9SBMBS«S«S=rsz
CERIOOAPHNIA DUBIA
TOXICITY DATA
(1 / ET50) X 100X
0.0
3,
17.
8.
10.
17.
32.
10.8
H
TABLE 0.24 TABLE 0.25
TIME LETHALITY TOXICITY UMIT DATA
FOR FIGURE 4.U(A)
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.U(B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 1/2A/89
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 1/24/89
FAYETTEVILLE CROSSCREEK WUTP MINUS C18T 8E«IE8 BLANKS
SAMPLE TAKEN BEFORE CHLORINATION
COMPOSITE SAMPLE 1/16/89 TO 1/17/89
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
FAYETTEVILLE CROSSCREEK UUTP MINUS C18T SERIES BLANKS
SAMPLE TAKEN BEFORE CHLORINATION
COMPOSITE SAMPLE 1/16/89 TO 1/17/89
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
=)eSE«assss!»SE=sssc«8t9«acssiex««»ssss esKzsBMsescEESESssssBssEssssssssEssasESsrssssssassssssssrsa
VOLUME OF SAMPLE
PASSED THROUGH
C-18 COLUMN (mis)
ssss==sssE=s==s=ss=scS8asscseBSSsscsKsss««Ksseszst:a
BEFORE COLUMN
50
250
450
I TIME BASED TOXICITY
UNIT (TTU)
11.3
0.0
0.0
0.0
s==rs3«m««BssssssSBas«csasar
SPE C-18 COLUMN EXTRACTION
PERCENT METHANOL / WATER
ELUTION
Kasesaaaassac
25
50
75
80
85
90
95
100
TIME BASED TOXICITY
UMIT (TTU)
saaseacaa
0.0
0.0
1.6
12.7
U.5
3.5
0.0
0.7
(-0.3)
ͣaeaesaaas sessaeaasesassa
O
TABLE 0.26 TABLE 0.27
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.15(A)
TIME LETHALITY TOXICITY UNIT DATA
FOR FIGURE 4.15(A)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 2/3/89
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 2/3/89
FAYETTEVILLE CROSSCREEK UUTP MINUS CIST SERIES BLANKS
SAMPLE TAKEN BEFORE CHLORIHATION
COMPOSITE SAMPLE 1/30/89 TO 1/31/89
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
FAYETTEVILLE CROSSCREEIC UUTP MINUS C18T SEItiES BLANKS
SAMPLE TAKEN BEFORE CHLORIHATION
COMPOSITE SAMPLE 1/30/89 TO 1/31/89
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
ssssr=ass=s=s=s=ssssssssssiessss9sasssK=ssssseassssss
1   VOLUME OF SAMPLE   | 1 TIME BASED TOXICITY |
1    PASSED THROUGH    | 1    UNIT (TTU)     1
1   C-18 COLUMN (mis)  1
1   BEFORE COLUMN     1 1        1-7        I
1       100         1 1               c-o               1
I       500          1 1               c-o               1
1       750         1 1        0.0                    1
1       850         1 1        0.0        1
1       950         1
1                  1
1       0.0       1
==ss)nHnnnnss=rrsse«csBs=
s===s=s««=SB=ss=s«=rss====s==r=Bra==a==s=======aa=ss=ss=s=s===s=
1   SPE C-18 COLUMN EXTRACTION | |    TIME BASED TOXICITY  |
1    PERCENT METHANOL / WATER  | |       UNIT (TTU)      |
1          ELUTION           1 1 1
=er==BS«assm=e==s====a=»BJ!ssssBsaa==asrsBsasas=a===»a
1           25           II         0.3
1           50           II         0.0 (-0.5)  1
1           75           II         6.4
1           80           II         6.2
1           85           II         0.5
1           90           II         0.0 (-1.2)  1
1           95           II         0.0
1          100           II         2.1
1                       1 1
asBBa«««»«««BB8aBB=S3B»K»««B«H««Bas=aa««m«am«iBaa3gBBgSSSSSfiSSSSS
$TABLE D.28 TABLE D.29
TIME LETHALITT TOXICITY UNIT DATA
FOR FIGURE 4.16(A)
TIME LETHALITY TOXICITT WIT DATA
FOR FIGURE 4.16(B)
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 3/2A/89
FRACTIONATION SPE C-18 COLUMN
BIOASSAY STARTED ON 3/24/89
FAYETTEVILLE CROSSCREEK UVTP MINUS C18T SERIES HANKS
SAMPLE TAKEN BEFORE CHLORINATION
COMPOSITE SAMPLE 3/20/89 TO 3/21/89
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
FAYETTEVILLE CROSSCREEK UUTP MINUS C18T ttStES HANKS
SAMPLE TAKEN BEFORE CHLORINATION
COMPOSITE SAMPLE 3/20/89 TO 3/21/89
1.5X METHANOL EXTRACTION
BIOASSAY CONDUCTED IN PLASTIC CUPS
VOLUME OF SAMPLE
PASSED THROUGH
C-18 COLUMN (mla)
BEFORE COLUMN
100
500
750
850
950
TINE BASED TOXICITY
UNIT (TTU)
8.8
0.0
0.0
0.0
0.0
0.0
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaai
SPE C-18 COLUMN EXTRACTION
PERCENT METHANOL / WATER
ELUTION
25
50
75
80
85
90
95
100
laaaaaaaaa
TIME BASED TOXICITY
UNIT (TTU)
0.0
0.0
5.4
7.6
7.0
3.7
0.0
0.0
(-4.6)
(-1.4)
(-2.7)
ͣsaacaaaa aaaaaaaaaaaaaaaaaa
H
